☒
|
| |
Preliminary Proxy Statement
|
☐
|
| |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐
|
| |
Definitive Proxy Statement
|
☐
|
| |
Definitive Additional Material
|
☐
|
| |
Soliciting Material under §240.14a-12
|
☐
|
| |
No fee required.
|
|||
☒
|
| |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|||
|
| |
(1)
|
| |
Title of each class of securities to which transaction applies: Taubman Centers, Inc. Common Stock, par value $0.01 (“Taubman common stock”) and Series B Non-Participating Convertible Preferred Stock, par value $0.001 per share (“Taubman Series B preferred stock”).
|
|
| |
|
| |
|
|
| |
(2)
|
| |
Aggregate number of securities to which the transaction applies:
|
|
| |
|
| |
61,608,379 shares of Taubman common stock
|
|
| |
|
| |
598,189 shares of Taubman common stock subject to issuance upon the settlement of outstanding equity awards pursuant to the Taubman Stock Plans (as defined below).
|
|
| |
|
| |
27,012,863.8 shares of Taubman common stock issuable upon conversion of 27,012,863.8 outstanding units of partnership interest in The Taubman Realty Group Limited Partnership, including 44,844 Taubman Incentive Units (as defined below) and 871,261.76 Option Deferred units (as defined below).
|
|
| |
|
| |
26,079,159 shares of Taubman Series B preferred stock.
|
|
| |
|
| |
|
|
| |
(3)
|
| |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): Solely for the purpose of calculating the filing fee, the underlying value of the transaction was calculated based on the sum of (a) the product of (i) 89,219,431.8 shares of Taubman common stock (including 598,189 shares of Taubman common stock subject to issuance upon the settlement of outstanding equity awards pursuant to the Taubman Stock Plans and 27,012,863.8 shares of Taubman common stock issuable upon conversion of 27,012,863.8 outstanding units of partnership interest in The Taubman Realty Group Limited Partnership, including 44,844 Taubman Incentive Units and 871,261.76 Option Deferred units) and (ii) the common stock merger consideration of $52.50 and (b) the product of (A) 26,079,159 shares of Taubman Series B preferred stock and (B) the Series B preferred stock merger consideration of $52.50 divided by 14,000 (collectively, the “Total Consideration”). The filing fee equals the product of 0.0001298 multiplied by the Total Consideration.
|
|
| |
|
| |
|
|
| |
(4)
|
| |
Proposed maximum aggregate value of transaction: $4,684,117,966.35
|
|
| |
|
| |
|
|
| |
(5)
|
| |
Total fee paid: $607,998.51
|
|
| |
|
| |
|
☐
|
| |
Fee paid previously with preliminary materials.
|
|||
☐
|
| |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
| |
(1)
|
| |
Amount Previously Paid:
|
|
| |
|
| |
|
|
| |
(2)
|
| |
Form, Schedule or Registration Statement No.:
|
|
| |
|
| |
|
|
| |
(3)
|
| |
Filing Party:
|
|
| |
|
| |
|
|
| |
(4)
|
| |
Date Filed:
|
|
| |
|
| |
|
|
| |
Sincerely yours,
|
| |
|
|
| |
|
| ||
|
| |
Chris Heaphy
Secretary |
| |
|
(1)
|
a proposal to adopt and approve an Agreement and Plan of Merger, dated as of February 9, 2020 (as it may be amended from time to time, which we refer to as the “merger agreement”), by and among Simon Property Group, Inc. (“Simon”), Simon Property Group, L.P. (the “Simon operating partnership”), Silver Merger Sub 1, LLC (“Merger Sub 1”), Silver Merger Sub 2, LLC (“Merger Sub 2” and together with Simon, the Simon operating partnership and Merger Sub 1, the “Simon parties”), the Company and The Taubman Realty Group Limited Partnership (the “Taubman operating partnership”), and the transactions contemplated thereby (the “Transactions”), including the merger of the Company with and into Merger Sub 1 (the “REIT Merger”) (such proposal, the “Merger Agreement Proposal”);
|
(2)
|
a non-binding, advisory proposal to approve compensation that may become payable to the named executive officers of the Company in connection with the REIT Merger and the other Transactions (the “Advisory Compensation Proposal”); and
|
(3)
|
a proposal to approve an adjournment of the special meeting, even if a quorum is present, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the Merger Agreement Proposal (the “Adjournment Proposal”).
|
|
| |
PAGE
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
|
| |
PAGE
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
•
|
“Acceptable Confidentiality Agreement” means an agreement with Taubman that is either (i) in effect as of the execution and delivery of the merger agreement; or (ii) executed, delivered and effective after the execution and delivery of the merger agreement, in either case containing provisions that require any counterparty thereto (and any of its affiliates and representatives named therein) that receive material non-public information of, or with respect to, Taubman to keep such information confidential that, in each case, contains confidentiality and use provisions that are no less restrictive to such counterparty (and any of its affiliates and representatives as provided therein) than the terms of the Mutual Non-Disclosure Agreement, dated as of November 8, 2019, between Taubman and Simon (it being understood that such agreement need not contain any “standstill” or similar provisions or otherwise prohibit the making of any Acquisition Proposal); provided, that in no event will any agreement that permits the counterparty thereto to enter into exclusive arrangements (other than customary “tree” arrangements) with potential financing sources be considered an “Acceptable Confidentiality Agreement.”
|
•
|
“Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Simon, the Simon operating partnership, Merger Sub 1 or Merger Sub 2) to engage in an Acquisition Transaction.
|
•
|
“Acquisition Transaction” means any transaction or series of related transactions (other than the Transactions) providing for:
|
○
|
any direct or indirect acquisition (whether by merger, consolidation or otherwise) of more than 15% of the voting power of Taubman or the Taubman operating partnership by any person or group;
|
○
|
any consolidation, business combination, reorganization, share exchange, sale of assets, recapitalization, equity investment, joint venture, liquidation, dissolution or other similar transaction involving Taubman or the Taubman operating partnership that would result in any person or group, directly or indirectly, acquiring assets (including capital stock of or interests in any subsidiary or affiliate of Taubman) representing, directly or indirectly, more than 15% of the consolidated assets of Taubman and its subsidiaries, taken as a whole (as determined on a book value basis (including indebtedness secured solely by such assets));
|
○
|
any tender offer or exchange offer or any other direct or indirect purchase or other acquisition of securities, that, if consummated, would result in any person or group, whether from Taubman or any other person(s), beneficially owning more than 15% of the outstanding shares of Taubman common stock or more than 15% of the outstanding Taubman OP units;
|
○
|
any other transaction or series of related transactions pursuant to which any person or group proposes to acquire, directly or indirectly, control of assets of Taubman or any of its subsidiaries having a fair market value greater than 15% of the fair market value of all of the assets of Taubman and its subsidiaries, taken as a whole, immediately prior to such transaction; or
|
○
|
any combination of the foregoing.
|
•
|
“Advisory Compensation Proposal” means the non-binding, advisory proposal to approve compensation that may become payable to the named executive officers of the Company in connection with the REIT Merger and the other Transactions.
|
•
|
“Adjournment Proposal” means the proposal to approve an adjournment of the special meeting, even if a quorum is present, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the Merger Agreement Proposal.
|
•
|
“Cash Tender Agreement” means the Amended and Restated Cash Tender Agreement, dated as of May 16, 2000, by and among Taubman, the Taubman operating partnership, and A. Alfred Taubman, A. Alfred Taubman, acting not individually but as Trustee of the A. Alfred Taubman Restated Revocable Trust (the “Revocable Trust”), and TRA Partners.
|
•
|
“closing” means the closing of the Transactions.
|
•
|
“Code” means the U.S. Internal Revenue Code of 1986, as amended.
|
•
|
“common stock merger consideration” means $52.50 in cash for each share of Taubman common stock.
|
•
|
“Compensation Committee” means the compensation committee of the Taubman Board.
|
•
|
“Continuing Offer” means the Second Amended and Restated Continuing Offer, dated as of May 16, 2000, by Taubman to certain holders of Taubman OP units and Taubman Incentive Units.
|
•
|
“DRULPA” means the Delaware Revised Uniform Limited Partnership Act.
|
•
|
“excess threshold” means $10 million annually, determined in aggregate (and based on absolute value) with respect to all instances where such term is used in the JV agreement (except that any action, project or expenditure that is approved or ratified by the board of the Joint Venture will not reduce or count against such figure).
|
•
|
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
|
•
|
“family transferee” means certain immediate family members or related entities of the Taubman family.
|
•
|
“FFO” means funds from operations.
|
•
|
“GAAP” means generally accepted accounting principles as applied in the United States.
|
•
|
“go-shop period” means the period beginning on February 9, 2020 (the date of the merger agreement) and continuing until 11:59 p.m., New York City time, on March 25, 2020 (the 45th day after the date of the merger agreement).
|
•
|
“G. Taubman Kalisman” means Gayle Taubman Kalisman.
|
•
|
“IRS” means the U.S. Internal Revenue Service.
|
•
|
“Joint Venture” means the Surviving Taubman operating partnership after it is converted into a limited liability company in the LLC Conversion.
|
•
|
“Joint Venture unit” means one unit of limited liability company interests in the Joint Venture.
|
•
|
“JV agreement” means the operating agreement of the Joint Venture.
|
•
|
“LLC Conversion” means the conversion of the Surviving Taubman operating partnership into a Delaware limited liability company.
|
•
|
“Manager” means The Taubman Company LLC.
|
•
|
“MBCA” means the Michigan Business Corporation Act.
|
•
|
“merger agreement” means the Agreement and Plan of Merger, dated as of February 9, 2020, as it may be amended from time to time, by and among Simon, the Simon operating partnership, Merger Sub 1, Merger Sub 2, the Company and the Taubman operating partnership.
|
•
|
“Merger Agreement Proposal” means the proposal to adopt and approve the merger agreement and the Transactions, including the REIT Merger.
|
•
|
“Mergers” means the REIT Merger and the Partnership Merger.
|
•
|
“Merger Sub 1” means Silver Merger Sub 1, LLC.
|
•
|
“Merger Sub 2” means Silver Merger Sub 2, LLC.
|
•
|
“Michigan LARA” means the Corporations, Securities & Commercial Licensing Bureau of the State of Michigan Department of Licensing and Regulatory Affairs.
|
•
|
“minority partners” means the holders of Taubman OP units (other than Taubman) who are not the Taubman family members.
|
•
|
“NAV” means net asset value.
|
•
|
“NOI” means net operating income.
|
•
|
“NYSE” means the New York Stock Exchange.
|
•
|
“Option Deferral Agreement” means that certain Amended and Restated Option Deferral Agreement, dated as of January 27, 2011, by and among R. Taubman, the Taubman operating partnership and the Manager, together with that certain Subsequent Deferral Election under the Taubman operating partnership and The Taubman Company LLC Election and Option Deferral Agreement, dated as of October 7, 2016.
|
•
|
“Option Deferred unit” means a right to receive a Taubman OP unit that has been deferred by R. Taubman pursuant to the Option Deferral Agreement.
|
•
|
“Partnership Merger” means the merger of Merger Sub 2 with and into the Taubman operating partnership, with the Taubman operating partnership surviving such merger.
|
•
|
“Projections” means certain non-public financial projections as to the potential future performance of Taubman for the years 2020 through 2024 prepared by Taubman’s management at the direction of the Special Committee in connection with the Transactions.
|
•
|
“Redemption” means the redemption of the Taubman Series J Preferred Stock and Taubman Series K Preferred Stock.
|
•
|
“REIT” means a real estate investment trust within the meaning of Section 856 of the Code.
|
•
|
“REIT Merger” means the merger of the Company with and into Merger Sub 1, with Merger Sub 1 surviving such merger.
|
•
|
“R. Taubman” means Robert S. Taubman.
|
•
|
“SEC” means the Securities and Exchange Commission.
|
•
|
“Series B preferred stock merger consideration” means an amount in cash equal to the common stock merger consideration (i.e., $52.50 in cash), divided by 14,000 for each share of Taubman Series B preferred stock.
|
•
|
“Severance Plan” means the Severance Plan for Senior Level Management of the Company, approved by the Compensation Committee on December 11, 2017, as reinstated by the Compensation Committee on February 9, 2020.
|
•
|
“shareholders of the Company” or “Company shareholders” or “Taubman shareholders” means, holders of the Taubman common stock and the Taubman Series B preferred stock, as the context may require.
|
•
|
“Simon” means Simon Property Group, Inc.
|
•
|
“Simon operating partnership” means Simon Property Group, L.P.
|
•
|
“Simon operating partnership preferred contribution” means the contribution, immediately following the effective time of the LLC Conversion, by the Simon operating partnership to the capital of the Joint Venture of an amount equal to the aggregate Taubman Series J and Series K Preferred Stock liquidation preference in exchange for a certain number of Series A Preferred Units (as defined in the JV agreement).
|
•
|
“Simon OP unit” means limited partnership units in the Simon operating partnership.
|
•
|
“Simon parties” means Simon, the Simon operating partnership, Merger Sub 1 and Merger Sub 2.
|
•
|
“Simon Period” means the period following the Taubman Period.
|
•
|
“Special Committee” means the special committee of the Taubman Board.
|
•
|
“Superior Proposal” means any written Acquisition Proposal for an Acquisition Transaction on terms that the Taubman Board (or the Special Committee) has determined in good faith (after consultation with its financial advisor and outside legal counsel), taking into account all legal, financial and regulatory aspects of such Acquisition Proposal, would be more favorable, from a financial point of view, to the shareholders of Taubman (in their capacity as such) than the Transactions. For purposes of the reference to an “Acquisition Proposal” and “Acquisition Transaction” in this definition, all references to “15%” in the definition of “Acquisition Transaction” will be deemed to be references to “75%.”
|
•
|
“Surviving Taubman operating partnership” means the Taubman operating partnership after the effective time of the Partnership Merger.
|
•
|
“Surviving TCO” means Merger Sub 1 after the effective time of the REIT Merger.
|
•
|
“Taubman” or the “Company” or “TCO” means Taubman Centers, Inc.
|
•
|
“Taubman Board” means the board of directors of the Company.
|
•
|
“Taubman common stock” means the common stock, par value $0.01 per share, of Taubman.
|
•
|
“Taubman Equity Awards” means, collectively, TCO RSUs, TCO PSUs, TCO DSUs, TCO DERs, Taubman Incentive Units, and Option Deferred units.
|
•
|
“Taubman family” means, collectively, the Taubman family members.
|
•
|
“Taubman family members” means R. Taubman, W. Taubman, and certain entities and trusts affiliated with R. Taubman, with W. Taubman, or with other members of their immediate family.
|
•
|
“Taubman family representative” means R. Taubman, in his capacity as the Taubman family representative (or another duly appointed representative of the Taubman family members).
|
•
|
“Taubman filing persons” means R. Taubman, W. Taubman and TVG.
|
•
|
“Taubman Incentive Unit” means an incentive partnership unit granted pursuant to any Taubman Stock Plan that is intended to constitute a “profits interest” within the meaning of the Code and the regulations promulgated thereunder, and IRS Revenue Procedure 93-27 and IRS Revenue Procedure 2001-43, and that has been granted pursuant to a “Profits Units Designation” as defined in the Taubman OP Agreement.
|
•
|
“Taubman non-voting preferred stock” means, collectively, the Taubman Series J Preferred Stock and the Taubman Series K Preferred Stock.
|
•
|
“Taubman OP agreement” means the Third Amendment and Restatement of Agreement of Limited Partnership of the Taubman operating partnership, dated as of December 12, 2012, as amended by that First Amendment dated as of June 1, 2016, by that Second Amendment dated as of December 18, 2018 and as may be subsequently amended from time to time.
|
•
|
“Taubman OP payment” means the payment, immediately after the Simon operating partnership preferred contribution, by the Joint Venture to Taubman in an amount equal to the aggregate Taubman Series J and Series K Preferred Stock liquidation preference.
|
•
|
“Taubman operating partnership” or “TRG” means The Taubman Realty Group Limited Partnership.
|
•
|
“Taubman OP unit” means a unit of partnership interest in the Taubman operating partnership.
|
•
|
“Taubman Period” means the period beginning on the effective date of the JV agreement and upon the occurrence of specified events set forth in the JV agreement (including the Taubman family members’ ownership of the Joint Venture falling below a specified threshold).
|
•
|
“Taubman Series B preferred stock” means the Series B Non-Participating Convertible Preferred Stock, par value $0.001 per share, of Taubman.
|
•
|
“Taubman Series J Preferred Stock” means the Series J Cumulative Redeemable Preferred Stock, no par value, of Taubman.
|
•
|
“Taubman Series J and Series K Preferred Stock Redemption Amount” means cash in immediately available funds in the amount of $25.00 plus all accumulated and unpaid dividends to, but not including, the redemption date set forth in the notice of redemption, per share of Taubman Series J Preferred Stock and Taubman Series K Preferred Stock, respectively.
|
•
|
“Taubman Series K Preferred Stock” means the Series K Cumulative Redeemable Preferred Stock, no par value, of Taubman.
|
•
|
“Taubman shareholder approval” means, collectively, the approval of the Merger Agreement Proposal by: (i) the holders of at least two-thirds of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class); (ii) the holders of at least a majority of the outstanding shares
|
•
|
“Taubman Stock Plans” means collectively, the Taubman 2008 Omnibus Long-Term Incentive Plan and the Taubman 2018 Omnibus Long-Term Incentive Plan.
|
•
|
“Taubman voting stock” means the Taubman common stock and the Taubman Series B preferred stock.
|
•
|
“TCO DER” means a dividend equivalent right granted in tandem with any TCO RSU or TCO PSU.
|
•
|
“TCO DSU” means a right to receive a share of Taubman common stock that has been deferred pursuant to any Taubman Stock Plan (excluding under the Option Deferral Agreement).
|
•
|
“TCO PSU” means an outstanding performance-based stock unit award of TCO granted under the TCO Stock Plans that vests in whole or in part on the basis of the achievement of performance targets.
|
•
|
“TCO RSU” means a restricted stock unit award of TCO granted under the TCO Stock Plans that vests solely on the basis of a recipient’s service to TCO or its affiliates.
|
•
|
“Transactions” means the transactions contemplated by the merger agreement, including the Mergers.
|
•
|
“TVG” means Taubman Ventures Group LLC.
|
•
|
“unaffiliated security holders” means unaffiliated security holders as defined under Rule 13e-3 of the Exchange Act.
|
•
|
“voting agreement” refers to the voting agreement, dated as of February 9, 2020, by and among Simon and the Taubman family members that own Taubman voting stock or Taubman OP units.
|
•
|
“W. Taubman” means William S. Taubman.
|
•
|
receipt of Taubman shareholder approval from (i) the holders of at least two-thirds of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class); (ii) the holders of at least a majority of the outstanding shares of Taubman Series B preferred stock entitled to vote thereon; and (iii) the holders of at least a majority of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class), excluding the outstanding shares of Taubman voting stock owned of record or beneficially by the Taubman family members;
|
•
|
receipt of Taubman operating partnership approval, and such approval must not have been rescinded, modified or withdrawn;
|
•
|
no law, judgment, legal restraint, prohibition or binding order shall be in effect, or imminently threatened by any governmental entity of competent jurisdiction, which prohibits, makes illegal, enjoins, or otherwise prevents the consummation of the Transactions; and
|
•
|
the shares of Simon common stock to be reserved for issuance upon exchange or redemption of Simon OP units issued or issuable to holders of Taubman OP units in the Transactions have been approved for listing on the NYSE.
|
•
|
the accuracy of the representations and warranties of Taubman and the Taubman operating partnership, subject to certain materiality standards as described under the section entitled “The Merger Agreement—Conditions to the Completion of the Transactions;”
|
•
|
the performance by Taubman and the Taubman operating partnership in all material respects of their covenants under the merger agreement;
|
•
|
the absence of a material adverse effect with respect to Taubman;
|
•
|
the receipt of an officer’s certificate certifying that the foregoing conditions have been satisfied; and
|
•
|
the receipt of a tax opinion of Honigman LLP, tax counsel to Taubman (or, if Honigman LLP is unable or unwilling to render such opinion, Kirkland & Ellis LLP or another nationally recognized REIT counsel as may be reasonably acceptable to Simon) with respect to Taubman’s qualification and taxation as a REIT under the Code.
|
•
|
the accuracy of the representations and warranties of the Simon parties, subject to certain materiality standards as described under the section entitled “The Merger Agreement—Conditions to the Completion of the Transactions;”
|
•
|
the performance by the Simon parties in all material respects of their covenants under the merger agreement; and
|
•
|
the receipt of an officer’s certificate certifying that the foregoing conditions have been satisfied.
|
•
|
prior to November 9, 2020, if, on the date that closing would otherwise have occurred, any investigation or legal action by any governmental entity is then-pending that, in Simon’s reasonable judgment, following consultation with Taubman and the Taubman family representative, is seeking or would reasonably be expected to lead to or result in a Simon Burdensome Condition (as further described under “The Merger Agreement—Regulatory Matters”), or
|
•
|
prior to July 9, 2020, if, on the date that the closing would otherwise have occurred, consents and waivers with respect to the Transactions (as described under “The Merger Agreement—Certain Consents; Treatment of Existing Debt”) have not been obtained from certain third parties or, with respect to any such consent under a loan document that has not been obtained, the underlying loan has not been prepaid or defeased.
|
•
|
at the effective time of the Partnership Merger, (i) each Taubman OP unit issued and outstanding immediately prior to the effective time of the Partnership Merger held by a minority partner will be converted into the right to receive, at the election of such minority partner, the common stock merger consideration or 0.3814 new Simon OP units; (ii) certain Taubman OP units issued and outstanding immediately prior to the effective time of the Partnership Merger held by the Taubman family members will remain outstanding as units of partnership interest in the Surviving Taubman operating partnership; and (iii) all other Taubman OP units issued and outstanding immediately prior to the effective time of the Partnership Merger held by the Taubman family members will be converted into the right to receive the common stock merger consideration;
|
•
|
immediately following the effective time of the Partnership Merger, at the effective time of the LLC Conversion, the Surviving Taubman operating partnership will be converted into a Delaware limited liability company pursuant to the LLC Conversion, in which each unit of partnership interest in the Surviving Taubman operating partnership that is owned by the Taubman family members, Merger Sub 1 or by Taubman immediately prior to the effective time of the LLC Conversion will be converted into one Joint Venture unit;
|
•
|
immediately prior to the effective time of the REIT Merger, Taubman will issue a redemption notice and cause funds to be set aside to pay the redemption price for each share of Taubman Series J Preferred Stock and Taubman Series K Preferred Stock, at their respective liquidation preference of $25.00 plus all accumulated and unpaid dividends to, but not including, the redemption date of such share (the “Redemption”); and
|
•
|
at the effective time of the REIT Merger, (i) each share of Taubman common stock issued and outstanding immediately prior to the effective time of the REIT Merger (other than certain excluded shares) will be converted into the right to receive the common stock merger consideration; and (ii) each share of Taubman Series B preferred stock will be converted into the right to receive the Series B preferred stock merger consideration.
|
•
|
The vesting of certain outstanding and unvested TCO RSUs and TCO PSUs, as applicable, held by executive officers of the Company will be accelerated pursuant to their terms (except that TCO PSUs granted prior to 2020 will become vested based on the greater of the average of actual performance achievement, as of the closing, of the two performance metrics applicable to such grants, and target performance), and the executive officers will receive the common stock merger consideration in respect of such awards pursuant to the merger agreement in connection with the completion of the Transactions.
|
•
|
TCO RSUs and TCO PSUs held by executive officers of the Company, the vesting of which will not be accelerated pursuant to their terms (including awards that were granted in March of 2020 in the ordinary course of business consistent with past practice), will be converted into cash substitute awards, on a per share basis, in an amount equal to the common stock merger consideration, which will become vested and paid in accordance with the same service-vesting schedule that applied to the original TCO RSU or TCO PSU award (and for TCO PSUs that were granted in March of 2020, in accordance with performance-vesting conditions, which will, after the closing, vest based solely on achievement of pre-established NOI growth targets), and paid if and to the extent they become vested in accordance with their terms after the Transactions. These cash substitute awards are also generally subject to vesting upon a qualifying termination of employment occurring within two years after the completion of the Transactions.
|
•
|
TCO DSUs held by directors, to the extent unvested as of the closing of the Transactions, will become fully vested and the directors will receive the common stock merger consideration in respect of such awards pursuant to the merger agreement in connection with the completion of the Transactions.
|
•
|
TCO DERs that relate to any TCO RSUs or TCO PSUs will be treated in the same manner as the TCO RSUs or TCO PSUs, as applicable, to which the TCO DER relates, with TCO DERs that relate to TCO RSUs or TCO PSUs that become cash substitute awards continuing to accrue, at the rate set forth in the merger agreement (a “cash substitute DER”), and will be paid if and to the same extent the cash substitute awards to which the TCO DERs relate become vested and payable in accordance with their terms after the completion of the Transactions.
|
•
|
Time-vesting and performance-vesting Taubman Incentive Units that vest in accordance with their terms in connection with the closing of the Transactions will vest and will automatically convert into a Taubman OP unit (with such performance-vesting Taubman Incentive Units vesting based on the greater of the average of actual performance achievement, as of the closing, of the two performance metrics applicable to such grants, and target performance), which shall then be treated in the same manner (and have the right to the same election) as all other Taubman OP units held by the minority partners.
|
•
|
At the effective time of the LLC Conversion, the Option Deferral Agreement will be deemed to be amended so that each Option Deferred unit will represent the right to receive, following the LLC Conversion, one Joint Venture unit, and will remain subject to all other terms and conditions of the Option Deferral Agreement.
|
•
|
The Company’s executive officers as of the effective time of the Transactions are expected to remain the executive officers of the Joint Venture.
|
•
|
Executive officers (other than R. Taubman and W. Taubman) are entitled to severance benefits if they experience a qualifying termination of employment within a specified period following the closing of the Transactions, which benefits include cash payments in respect of lost base salary and bonus amounts and accelerated vesting of cash substitute awards (described below), among other benefits.
|
•
|
The Company’s directors and executive officers are entitled to continued indemnification and insurance coverage under the merger agreement, the Company’s articles of incorporation and Surviving TCO’s limited liability company agreement.
|
•
|
by mutual written consent of Taubman and Simon;
|
•
|
if the Transactions have not been completed on or before February 9, 2021 (the “end date”);
|
•
|
if any governmental entity of competent authority issues a final, non-appealable order or enacts an applicable law that prohibits, makes illegal, enjoins, or otherwise restricts or prevents the consummation of the Transactions; or
|
•
|
if the Taubman shareholder approval has not been obtained at a duly convened meeting of Taubman shareholders.
|
•
|
at any time before the effective time of the REIT Merger, if the Simon parties have breached any representation, warranty or covenant contained in the merger agreement, or if any representation or warranty of such party has become untrue, in each case, such that, if such breach or failure to be true occurs or continues on the closing date, the conditions to closing relating to the accuracy of such party’s representations and warranties or the performance by such party of its covenants under the merger agreement would not be satisfied as of the closing date (subject, as applicable, to a 45-day cure period); or
|
•
|
prior to Taubman’s receipt of the Taubman shareholder approval, in order to enter into a definitive written agreement providing for a Superior Proposal in compliance with the “No-Shop” provisions of the merger agreement.
|
•
|
at any time before the effective time of the REIT Merger, if Taubman or the Taubman operating partnership has breached any representation, warranty or covenant contained in the merger agreement (other than the “No-Shop” provisions), or if any representation or warranty of such party has become untrue, in each case, such that, if such breach or failure to be true occurs or continues on the closing date, the conditions to closing relating to the accuracy of such party’s representations and warranties or the performance by such party of its covenants under the merger agreement would not be satisfied as of the closing date (subject, as applicable, to a 45-day cure period); or
|
•
|
prior to Taubman’s receipt of the Taubman shareholder approval, if a Taubman Board recommendation change has occurred or if Taubman has willfully breached the “No-Shop” provisions of the merger agreement.
|
•
|
The Merger Agreement Proposal;
|
•
|
The Advisory Compensation Proposal; and
|
•
|
The Adjournment Proposal.
|
Q:
|
When and where is the special meeting?
|
A:
|
[•] A.M., Eastern Time, on [•], 2020, at [•]. As part of our precautions regarding the coronavirus or COVID-19, the special meeting may be held solely by means of remote communication rather than in person. If we take this step, we will announce the decision to do so in advance and provide details on how to participate in a press release issued by the Company and on our website, www.taubman.com. We will also file the press release with the SEC as definitive additional solicitation material. We encourage you to vote by proxy—over the Internet, by telephone or by mail—well in advance of the special meeting, to ensure your shares are represented whether or not you decide to attend.
|
Q:
|
Who can attend and vote at the special meeting?
|
A:
|
All holders of Taubman common stock and Taubman Series B preferred stock as of the close of business on [•], 2020, the record date for voting at the special meeting, including shareholders of record and beneficial owners of Taubman common stock and Taubman Series B preferred stock registered in the “street name” of a bank, broker or other nominee, are invited to attend the special meeting. If you are a shareholder of record, please be prepared to provide proper identification, such as a driver’s license. If you hold your shares in “street name,” you will need to provide proof of ownership, such as a recent account statement or letter from your bank, broker or other nominee, along with proper identification.
|
Q:
|
What is a quorum?
|
A:
|
The presence at the special meeting, in person or, in the event that the special meeting is held by means of remote communication, virtually, or by proxy, of the holders of a majority of the shares of Taubman voting stock outstanding on the record date will constitute a quorum for all purposes. As of the record date, [•] shares of Taubman voting stock were outstanding, consisting of [•] shares of Taubman common stock and [•] shares of Taubman Series B preferred stock. If you submit a proxy but fail to provide voting instructions or abstain on any of the proposals listed on the proxy card, your shares will be counted for purpose of determining whether a quorum is present at the special meeting. If your shares are held in “street name” by your bank, broker or other nominee and you do not tell the bank, broker or other nominee how to vote your shares, these shares will not be counted for purposes of determining whether a quorum is present for the transaction of business at the special meeting.
|
Q:
|
How many votes do I have?
|
A:
|
At the special meeting, holders of Taubman common stock and Taubman Series B preferred stock will each have one vote per share that our records show are owned by such holder as of the record date.
|
Q:
|
What are the proposed Transactions?
|
A:
|
Pursuant to the merger agreement, subject to the satisfaction or waiver of certain conditions, in the Partnership Merger, Merger Sub 2 will be merged with and into the Taubman operating partnership and, in the REIT Merger, the Company will be merged with and into Merger Sub 1. Upon completion of the Partnership Merger, the Taubman operating partnership will survive, as the Surviving Taubman operating partnership, and the separate existence of Merger Sub 2 will cease. Upon completion of the REIT Merger, Merger Sub 1 will survive, as Surviving TCO, and the separate existence of the Company will cease. Immediately following the Partnership Merger, in the LLC Conversion, the Surviving Taubman operating partnership will be converted into the Joint Venture, a Delaware limited liability company.
|
Q:
|
What will holders of Taubman common stock receive in the REIT Merger?
|
A:
|
If the REIT Merger is completed, holders of shares of Taubman common stock (other than shares of Taubman common stock owned by the Company as treasury stock, by any direct or indirect wholly owned subsidiary of the Company, by any of the Simon parties or by any direct or indirect wholly owned subsidiary of the Simon parties) will be entitled to receive $52.50 in cash for each share of Taubman common stock issued and outstanding immediately prior to the effective time of the REIT Merger, without interest and less applicable withholding taxes.
|
Q:
|
What will holders of Taubman Series B preferred stock receive in the REIT Merger?
|
A:
|
If the REIT Merger is completed, holders of Taubman Series B preferred stock will be entitled to receive, for each share of Taubman Series B preferred stock held, an amount in cash equal to the common stock merger consideration, divided by 14,000.
|
Q:
|
What will holders of Taubman Equity Awards granted under the Taubman Stock Plans receive in the REIT Merger?
|
A:
|
Upon the effective time of the REIT Merger: (1) each outstanding TCO RSU and each outstanding TCO PSU that vests in accordance with its terms in connection with the closing of the REIT Merger will automatically convert into the right to receive the common stock merger consideration (with such TCO PSUs vesting based on the greater of the average of actual performance achievement, as of the closing, of the two performance metrics applicable to such grants, and target performance); (2) each outstanding TCO RSU and TCO PSU that is not eligible to vest in accordance with its terms in connection with the closing of the REIT Merger will be converted into a cash substitute award to be paid (A) with respect to any such award granted prior to 2020, in accordance with the same service-vesting schedule that applied to the original TCO RSU or TCO PSU award and (B) with respect to any such award granted in 2020, in accordance with the same vesting schedule (including performance-vesting conditions) that applied to the original TCO RSU or TCO PSU award; (3) each outstanding time-vesting and performance-vesting Taubman Incentive Unit will vest and be converted into a Taubman OP unit (with such Taubman Incentive Units vesting based on the greater of the average of actual performance achievement, as of the closing, of the two performance metrics applicable to such grants, and target performance), which shall then be treated in the same manner (and having the right to the same election) as all other Taubman OP units held by the minority partners; (4) each TCO DER granted in tandem with any TCO RSU or TCO PSU will be treated in the same manner as the outstanding TCO RSU or TCO PSU to which such TCO DER relates; and (5) each outstanding TCO DSU will be converted into the right to receive the common stock merger consideration. Finally, at the effective time of the LLC Conversion, the Option Deferral Agreement will be deemed to be amended so that each Option Deferred unit will represent the right to receive, following the LLC Conversion, one Joint Venture unit and will remain subject to all other terms and conditions of the Option Deferral Agreement.
|
Q:
|
How does the common stock merger consideration compare to the market price of the Taubman common stock prior to the announcement of the REIT Merger?
|
A:
|
The $52.50 per share to be paid in respect of each share of Taubman common stock represents: an implied premium of 98.7% to the closing price for Taubman common stock of $26.42 on January 31, 2020, the last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman, and a 51% premium to the closing price for the Taubman common stock on February 7, 2020 (the last trading day before the announcement of the merger agreement on February 10, 2020).
|
Q:
|
What matters will be voted on at the special meeting?
|
A:
|
You will be asked to vote on the following proposals:
|
•
|
the Merger Agreement Proposal;
|
•
|
the Advisory Compensation Proposal; and
|
•
|
the Adjournment Proposal.
|
Q:
|
How does the Taubman Board recommend that I vote?
|
A:
|
Based in part on the unanimous recommendation of the Special Committee, the Taubman Board unanimously recommends that our shareholders vote:
|
•
|
“FOR” the Merger Agreement Proposal;
|
•
|
“FOR” the Advisory Compensation Proposal; and
|
•
|
“FOR” the Adjournment Proposal.
|
Q:
|
What vote is required to approve the Merger Agreement Proposal?
|
A:
|
The Merger Agreement Proposal requires the approval of (1) the holders of at least two-thirds of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class), (2) the holders of at least a majority of the shares of the Taubman Series B preferred stock entitled to vote thereon, and (3) the holders of at least a majority of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class), but excluding the outstanding shares of Taubman voting stock owned of record or beneficially by the Taubman family members. If you fail to vote on the Merger Agreement Proposal, the effect will be the same as a vote against the Merger Agreement Proposal.
|
Q:
|
If my shares are held by my bank, broker or other nominee on my behalf in “street name,” will my bank, broker or other nominee vote my shares for me?
|
A:
|
No. In accordance with the rules of NYSE, banks, brokers and other nominees who hold Taubman voting stock in “street name” for their customers do not have discretionary authority to vote those shares with respect to the Merger Agreement Proposal, the Advisory Compensation Proposal, or the Adjournment Proposal. Accordingly, if banks, brokers or other nominees do not receive specific voting instructions from the beneficial owners of those shares, they are not permitted to vote those shares with respect to any of the proposals to be presented at the special meeting. As a result, if you hold your Taubman voting stock in “street name” and you do not provide voting instructions for any of the proposals, your Taubman voting stock will (1) not be counted for purposes of determining whether a quorum is present at the special meeting, (2) have the same effect as a vote “AGAINST” the Merger Agreement Proposal and Advisory Compensation Proposal and (3) assuming a quorum is present, have no effect on the Adjournment Proposal.
|
Q:
|
May I vote in person?
|
A:
|
Yes. Shareholders of record will be able to attend the special meeting in person and complete a written ballot or, in the event that the special meeting is held by means of remote communication, attend the special meeting virtually and complete a virtual ballot, whether or not you sign and return your proxy card. If you are not a shareholder of record, but instead your shares are held by a bank, broker or other nominee on your behalf in “street name,” you must provide a proxy executed in your favor from your bank, broker or other nominee in order to be able to vote in person at the special meeting or virtually in the event that the special meeting is held by means of remote communication. If you hold your shares through The Taubman Company and Related Entities Employee Retirement Savings Plan (the 401(k) plan), only Vanguard Fiduciary Trust Company, the trustee for the plan, may vote on your behalf. Accordingly, 401(k) plan participants may not vote their shares in person at the special meeting or virtually in the event that the special meeting is held by means of remote communication. We encourage you to vote by proxy—over the Internet, by telephone or by mail—well in advance of the special meeting, to ensure your shares are represented whether or not you decide to attend.
|
Q:
|
Will the Taubman family members vote their voting shares in favor of the merger agreement at the special meeting?
|
A:
|
Yes. The Taubman family members and Simon entered into a voting agreement in connection with the execution of the merger agreement. Under the voting agreement, subject to certain exceptions, the Taubman family members have covenanted to Simon to, among other things, vote any shares of Taubman voting stock owned by them in favor of the Merger Agreement Proposal at the special meeting. As of April 22, 2020, the Taubman family members, in aggregate, have the power to vote approximately 30% of the outstanding shares of Taubman voting stock. For a discussion of the Taubman family members’ obligation to Simon to vote in favor of the Merger Agreement Proposal, see “Special Factors—The Taubman Family Members’ Obligation to Simon to Vote in Favor of the Merger Agreement Proposal.”
|
Q:
|
What effects will the REIT Merger have on shares of Taubman common stock and Taubman Series B preferred stock?
|
A:
|
The shares of Taubman common stock are currently registered under the Exchange Act and are listed on NYSE under the symbol “TCO.” The shares of the Taubman Series B preferred stock are not registered under the Exchange Act and are not listed on a national securities exchange. As a result of the REIT Merger, the Company will become privately held and there will be no public market for shares of Taubman common stock or shares of Taubman Series B preferred stock. After the REIT Merger, the shares of Taubman common stock will cease to be listed on NYSE. In addition, registration of the Taubman common stock under the Exchange Act will be terminated.
|
Q:
|
Who will own the Company and the Taubman operating partnership after the Transactions?
|
A:
|
Upon completion of the REIT Merger, Merger Sub 1, a wholly owned subsidiary of the Simon operating partnership, will survive, as Surviving TCO, and the separate existence of the Company will cease. Upon completion of the Partnership Merger, the Taubman operating partnership will survive, as the Surviving Taubman operating partnership, and the separate existence of Merger Sub 2 will cease. Immediately following the Partnership Merger, the Surviving Taubman operating partnership will be converted in the LLC Conversion into the Joint Venture, a Delaware limited liability company. Following the Mergers and the LLC Conversion, the Simon operating partnership will own 100% of the outstanding equity of Surviving TCO, Surviving TCO will own 80% of the limited liability company interests of the Joint Venture and the Taubman family members will own the remaining 20% of the limited liability company interests of the Joint Venture.
|
Q:
|
What will happen if the Mergers are not consummated?
|
A:
|
If the Mergers are not consummated for any reason, the Company’s shareholders will not receive any payment for their shares in connection with the REIT Merger. Instead, the Company will remain a public company. The Taubman common stock will continue to be listed and traded on NYSE. Upon a termination of the merger agreement, under certain circumstances, the Taubman operating partnership will be required to pay a termination fee to Simon of $46,604,909 if such termination had occurred during the go-shop period (and for a limited period
|
Q:
|
What vote is required to approve the Advisory Compensation Proposal?
|
A:
|
Approval, on a non-binding, advisory basis, of the Advisory Compensation Proposal requires the affirmative vote of two-thirds of the shares of Taubman voting stock entitled to vote thereon, voting as a single class.
|
Q:
|
What will happen if shareholders do not approve the Advisory Compensation Proposal?
|
A:
|
The approval of the Advisory Compensation Proposal is not a condition to the completion of the Mergers or the other Transactions. SEC rules require the Company to seek approval on a non-binding, advisory basis of compensation payable to the Company’s named executive officers in connection with the Transactions. The vote on this proposal is an advisory vote and will not be binding on the Company or Simon. If the Merger Agreement Proposal is approved by Taubman shareholders and the Transactions are completed, the Transactions-related compensation may be paid to the Company’s named executive officers (to the extent such compensation becomes payable pursuant to its terms), even if shareholders fail to approve the Advisory Compensation Proposal.
|
Q:
|
What do I need to do now?
|
A:
|
We urge you to read this proxy statement carefully, including its annexes and the documents referred to as incorporated by reference in this proxy statement, as well as the related Schedule 13E-3, including the exhibits thereto, filed with the SEC, and to consider how the Mergers and the Transactions affect you. See “Where You Can Find Additional Information.”
|
•
|
the Internet, at the address provided on your proxy card;
|
•
|
telephone, using the toll-free number listed on your proxy card; or
|
•
|
mail, if you do not have access to the Internet or a touch-tone telephone. Please complete, sign, date and return your proxy card in the envelope provided.
|
Q:
|
Should I send in my stock certificates or other evidence of ownership now?
|
A:
|
No. After the Mergers are completed, you will receive a letter of transmittal with detailed written instructions for exchanging your shares of Taubman voting stock for the common stock merger consideration or the Series B preferred stock merger consideration, as applicable. If your shares of Taubman voting stock are held by a bank, broker or other nominee on your behalf in “street name,” you may receive instructions from your bank, broker or other nominee as to what action, if any, you need to take to effect the surrender of your “street name” shares in exchange for the common stock merger consideration or the Series B preferred stock merger consideration, as applicable. Do not send in your certificates now.
|
Q:
|
Can I revoke my proxy and voting instructions?
|
A:
|
Yes. Your proxy is revocable. If you are a shareholder of record, you may revoke your proxy at any time before the vote is taken at the special meeting by giving written notice of revocation to the Secretary of the Company, Chris Heaphy, 200 East Long Lake Road, Suite 300, Bloomfield Hills, Michigan 48304-2324, by giving written notice of revocation in person at the special meeting, by submitting a new proxy by Internet, using the telephone or by completing, signing, dating and returning a new proxy card by mail to the Company (at the address set forth above), or by attending the special meeting and voting in person or, in the event that the special meeting is held by means of remote communication, virtually (but simply attending the special meeting will not cause your proxy to be revoked).
|
Q:
|
What happens if I sell my shares of Taubman common stock or Taubman Series B preferred stock before completion of the REIT Merger?
|
A:
|
If you transfer your shares of Taubman common stock or Taubman Series B preferred stock, you will have transferred your right to receive the common stock merger consideration or the Series B preferred stock merger consideration, as applicable, in the REIT Merger. In order to receive the common stock merger consideration or the Series B preferred stock merger consideration, as applicable, you must hold your shares of Taubman common stock or Taubman Series B preferred stock, as applicable, through completion of the REIT Merger.
|
Q:
|
Will I have to pay U.S. federal income taxes on the common stock merger consideration I receive in the REIT Merger?
|
A:
|
The exchange of Taubman common stock for cash in the REIT Merger will be a taxable transaction for U.S. federal income tax purposes. A U.S. holder (as defined in the discussion under the heading “Special Factors—Material U.S. Federal Income Tax Consequences of the REIT Merger”) of Taubman common stock who receives cash in the REIT Merger is generally expected to recognize gain or loss in an amount equal to the difference, if any, between (1) the amount of cash received and (2) such U.S. holder’s adjusted tax basis in the Taubman common stock exchanged therefor. Subject to the exceptions discussed under the heading “Special Factors—Material U.S. Federal Income Tax Consequences of the REIT Merger—Non-U.S. Holders,” non-U.S. holders are generally not expected to be subject to U.S. federal income tax on the gain or loss recognized on cash received with respect to their Taubman common stock pursuant to the REIT Merger.
|
Q:
|
If I do not favor the approval and adoption of the merger agreement, what are my appraisal rights under Michigan law?
|
A:
|
If you are a holder of Taubman common stock or Taubman Series B preferred stock as of the record date, you can vote against the Merger Agreement Proposal. You do not have, however, any dissenters’ or appraisal rights with respect to the REIT Merger or the other Transactions, including any right to receive notice with respect to dissenters’ rights under Section 703a of the MBCA, any right or remedy under Sections 762 et seq. of the MBCA, any dissenters’ or appraisal rights under the DRULPA or any dissenters’ or appraisal rights under the Taubman OP agreement.
|
Q:
|
Who will solicit and pay the cost of soliciting proxies?
|
A:
|
The Company has retained Innisfree M&A Incorporated, a proxy solicitation firm, to assist it in the solicitation of proxies for the special meeting and will pay Innisfree M&A Incorporated a fee not to exceed $[•], plus reimbursement of out-of-pocket expenses. In addition, the Company has agreed to indemnify Innisfree M&A Incorporated against certain liabilities and expenses that relate to or arise out of its solicitation of proxies (subject to certain exceptions). Brokerage houses, nominees, fiduciaries and other custodians will be requested to forward soliciting materials to beneficial owners and will be reimbursed for their reasonable out-of-pocket expenses incurred in sending proxy materials to beneficial owners.
|
Q:
|
What is householding?
|
A:
|
We have elected to send a single copy of this proxy statement to any household at which two or more shareholders reside unless one of the shareholders at such address provides notice that he or she desires to receive individual copies or has elected e-mail delivery of proxy materials. A separate proxy card is included in the proxy materials for each of these shareholders. This “householding” practice reduces our printing and postage costs. If you would like to request additional copies of this proxy statement, you can request householding by contacting Innisfree M&A Incorporated as described under “Who can help answer my other questions?” below.
|
Q:
|
Who can help answer my other questions?
|
A:
|
If you have more questions about the special meeting, the Mergers or the other Transactions, or require assistance in submitting your proxy or voting your shares or need additional copies of the proxy statement or the enclosed proxy card(s), please contact Innisfree M&A Incorporated, which is acting as the proxy solicitation agent and information agent in connection with the Transactions:
|
•
|
the Special Committee’s belief and the Taubman Board’s belief that the consideration to unaffiliated Taubman shareholders per share of Taubman common stock, as further described under the section entitled “The Merger Agreement—REIT Merger—Treatment of Taubman Common Stock and Taubman Series B Preferred Stock,” was more favorable to such holders than the potential value that might result from other alternatives reasonably available to Taubman, including the alternative of remaining an independent company and pursuing Taubman’s current strategic plan, and other strategic or financial alternatives that might be undertaken as an independent company, in light of a number of factors, including the risks and uncertainties associated with those alternatives;
|
•
|
the current and historical market prices of Taubman common stock, including the fact that the consideration of $52.50 per share of Taubman common stock represents:
|
○
|
an implied premium of 98.7% to the closing share price for Taubman common stock of $26.42 on January 31, 2020, the last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman;
|
○
|
an implied premium of 51.4% to the closing share price for Taubman common stock of $34.67 on February 7, 2020, the last completed trading day before the announcement of the Transactions; and
|
○
|
an implied premium of 32.6% to the volume-weighted average price of $39.60 for the shares of Taubman common stock over the 52-week period ended January 31, 2020, the last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman;
|
•
|
the Special Committee’s and the Taubman Board’s respective reviews of Taubman’s business, operations, financial condition, strategy, prospects and the risk in achieving such prospects, as well as industry conditions and trends, and the Special Committee’s and the Taubman Board’s view that the consideration to be paid in connection with the Transactions was fair in light of Taubman’s business, operations, financial condition, strategy, prospects and the risk in achieving such prospects, as well as Taubman’s historical and projected financial performance, taking into account, among other things, the projections prepared by Taubman management with respect to Taubman’s prospects as an independent company, as further described below in the section entitled “—Certain Unaudited Prospective Financial Information”;
|
•
|
the Special Committee’s and the Taubman Board’s respective understandings of Taubman’s business, assets, financial condition and results of operations, its competitive position and historical and projected financial performance, and the nature and challenges of the retail property industry;
|
•
|
that the transaction consideration provides Taubman shareholders with immediate certainty of greater value and liquidity at an attractive per share equity value without the market or execution risks associated with continued independence;
|
•
|
the financial presentation of Lazard dated February 9, 2020, and the oral opinion of Lazard, subsequently confirmed by delivery of a written opinion dated February 9, 2020, rendered to the Special Committee, to the effect that, as of February 9, 2020, and based on and subject to the factors and assumptions set forth in the written opinion, the consideration to be paid to the Taubman common shareholders (other than Simon, the Taubman family members and any of their respective affiliates) pursuant to the merger agreement was fair from a financial point of view to such holders, as further described under “—Opinion of Financial Advisor to the Special Committee”;
|
•
|
that the merger agreement allows all unaffiliated holders of Taubman OP units to elect to receive (i) the same cash consideration to be received by Taubman shareholders or (ii) a number of Simon OP units equal to a fixed exchange ratio, as further described under “—Certain Effects of the Transactions—The Partnership Merger and LLC Conversion”;
|
•
|
that the exchange ratio with respect to the exchange of Taubman OP units for Simon OP units is fixed and will not be adjusted for fluctuations in the market price of Simon common stock and, because Simon OP units are convertible into shares of Simon common stock, the holders of Taubman OP units receiving Simon OP units in the Transactions will benefit from any increase in the trading price of Simon OP units between the announcement and the closing of the Transactions;
|
•
|
the Special Committee’s and the Taubman Board’s respective views that the consideration to be paid in the Transactions represented the highest per share consideration that could be reasonably obtained;
|
•
|
the fact that, during the period since discussions regarding the Transactions began until the signing of the merger agreement, share prices for both Taubman and Simon had declined;
|
•
|
that the Special Committee and the Taubman Board, with the assistance of their respective financial and legal advisors, had considered alternatives, including continuing to operate Taubman on a standalone basis, a sale of selected assets, a spin-off of selected assets or a sale to an alternative buyer, and considered the risks and uncertainties associated with such alternatives, and the Special Committee’s and the Taubman Board’s view that no other alternatives were reasonably likely to create greater value for Taubman common shareholders than the Transactions, taking into account the risk of execution as well as business, competitive, industry and market risk;
|
•
|
the fact that market rumors that Simon was engaging in discussions to acquire Taubman became public, which provided any third party wishing to engage in discussions with Taubman with an opportunity to make its interest known, and the fact that, although the Special Committee had not granted Simon exclusivity and was free to consider indications from any other party, no potential acquiror other than
|
•
|
the Special Committee’s and the Taubman Board’s review of the merger agreement, the structure of the Transactions and the financial and other terms and conditions of the Transactions;
|
•
|
the efforts made by the Special Committee, with the assistance of its legal and financial advisors, to be fully informed and to negotiate and execute transaction agreements as favorable to Taubman and the unaffiliated Taubman shareholders as possible, and the fact that extensive negotiations regarding the merger agreement were held between the Special Committee and its advisors and Simon and its advisors;
|
•
|
that the Taubman family members have agreed to negotiate in good faith with a competing bidder that has made a proposal which the Special Committee determines is a Superior Proposal, or is reasonably likely to lead to a Superior Proposal, and that has a structure similar to the Transactions, and that the Taubman family members have agreed to discuss in good faith with the Special Committee terms on which the Taubman family members might be willing to agree to an alternative transaction that does not have a structure similar to the Transactions;
|
•
|
the fact that during the go-shop period, the Special Committee and its advisors were permitted to solicit, initiate, propose or induce the making, submission or announcement of, or encourage, facilitate or assist, any proposal or offer that could constitute an acquisition proposal from a person other than Simon, and were permitted to terminate the merger agreement to accept a Superior Proposal from such person as long as Taubman paid the applicable termination fee to Simon and complied with certain other procedures in the merger agreement, as more fully described under “The Merger Agreement—The ‘Go-Shop’ Period”;
|
•
|
that the merger agreement permits the Special Committee to evaluate, negotiate and recommend that the Taubman Board approve a competing transaction, including that:
|
○
|
the Special Committee (or the Taubman Board acting on the Special Committee’s recommendation) may make a Taubman Board recommendation change prior to the approval and adoption of the merger agreement by the Taubman shareholders, subject to compliance with the merger agreement, if it determines in good faith (after consultation with its legal counsel and financial advisor) that, with respect to a Superior Proposal, the failure to take such action would be inconsistent with its fiduciary duties under applicable law; and
|
○
|
the merger agreement provides for the payment of a termination fee of either $46,604,909 (if the merger agreement had been terminated during the go-shop period or in certain circumstances for a limited time period thereafter) or $111,851,783 (if the merger agreement is terminated following the conclusion of such periods) to Simon if (i) Taubman terminates the merger agreement in connection with a Superior Proposal, (ii) Simon terminates the merger agreement in connection with a Taubman Board recommendation change or (iii) under specified circumstances, Taubman enters into a competing proposal within twelve months following a termination of the merger agreement. The Special Committee and the Taubman Board both believed that these fees are reasonable in light of the circumstances and the overall terms of the merger agreement, consistent with fees in comparable transactions, and not preclusive of other offers. For additional information, see the section entitled “The Merger Agreement—Termination” and “The Merger Agreement—Termination Fees”;
|
•
|
the other terms of the merger agreement, including the conditions to the closing of the Transactions, and that:
|
○
|
the merger agreement does not contain a financing condition with respect to any financing by Simon;
|
○
|
the merger agreement requires Simon to use its reasonable best efforts to obtain any necessary regulatory approvals, subject to certain limitations described in the section entitled “The Merger Agreement—Regulatory Matters”;
|
○
|
the outside date under the merger agreement on which either party, subject to specified exceptions, can terminate the merger agreement, should provide sufficient time to consummate the Transactions; and
|
○
|
the merger agreement permits Taubman to enforce specifically the terms of the merger agreement, and to seek damages in the event of a breach by Simon;
|
•
|
that Taubman would be permitted to continue to declare and pay its regular quarterly cash dividends to holders of Taubman common stock and accrue quarterly dividends to holders of eligible Taubman Equity Awards in each fiscal quarter through the closing of the Transactions (as well as any prorated dividends for the portion of any quarter in which the closing of the Transactions occurs, which may be declared prior to the closing of the Transactions and have a record and/or payment date immediately prior to closing of the Transactions), in each case, subject to the limits set forth in the merger agreement;
|
•
|
that the merger agreement is subject to the adoption by (i) the affirmative vote of the holders of at least two-thirds of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class), (ii) the affirmative vote of the holders of a majority of the outstanding shares of Taubman Series B preferred stock entitled to vote thereon and (iii) the affirmative vote of the holders of at least a majority of the outstanding shares of Taubman voting stock entitled to vote thereon (voting as a single class), excluding the outstanding shares of Taubman voting stock owned of record or beneficially by the Taubman family members;
|
•
|
that the merger agreement does not provide for a termination fee in the event that the Taubman shareholders do not approve the Transactions in the absence of a competing proposal; and
|
•
|
that the Taubman family members covenanted to Simon in the voting agreement to vote their shares of Taubman voting stock and their Taubman OP units in favor of the Transactions and that the voting agreement terminates automatically if the merger agreement is validly terminated and could be terminated by the Taubman family members if the Taubman Board changes its recommendation of the Transactions.
|
•
|
that the Special Committee was formed at the outset of the Transactions;
|
•
|
that the Special Committee consists of four directors who are independent of, and not affiliated with, Simon, the Taubman family members or any of their respective affiliates;
|
•
|
that the members of the Special Committee are disinterested with respect to the Transactions;
|
•
|
that the Special Committee had exclusive authority to decide whether or not to proceed with a transaction or any alternative thereto, subject to the Taubman Board’s approval of the Transactions as required by Michigan law;
|
•
|
that the Special Committee retained and was advised by its own legal and financial advisors;
|
•
|
that the Special Committee was empowered to, among other things: (i) review and evaluate the possible sale of Taubman; (ii) identify, review and evaluate alternatives to the possible sale of Taubman that may be available to Taubman, including remaining an independent company; (iii) if the Special Committee considers it advisable or appropriate, negotiate the price, structure, form, terms and conditions of a sale of Taubman or any alternative thereto and the form, terms and conditions of any definitive agreements in connection therewith; (iv) determine whether a sale of Taubman or any alternative thereto is fair to, advisable and in the best interests of Taubman and its shareholders; (v) engage, and obtain any necessary or desirable advice, assistance and opinions from, financial advisors or other advisors, consultants and agents; and (vi) recommend to the full Taubman Board what action, if any, should be taken by Taubman with respect to a sale of Taubman or any alternative thereto;
|
•
|
that the Special Committee had no obligation to recommend any transaction, including a transaction with Simon, and that the Special Committee had the authority to reject any proposals made by Simon or any other person;
|
•
|
that the Special Committee was involved in frequent and extensive deliberations over a period of more than three months regarding Simon’s proposal to acquire Taubman and the other transactions contemplated by the merger agreement, including 32 Special Committee meetings, and was provided with full access to Taubman management and its advisors in connection with its evaluation process;
|
•
|
that the merger agreement is subject to a “majority-of-the-minority” voting requirement, pursuant to which the consummation of the Transactions is subject to a condition that the merger agreement be approved and adopted by the affirmative vote of holders of a majority of the outstanding shares of Taubman voting stock not beneficially owned by the Taubman family members;
|
•
|
that the merger agreement provides for a “go-shop” period, during which the Special Committee and its advisors were permitted to solicit, initiate, propose or induce the making, submission or announcement of, or encourage, facilitate or assist, any proposal or offer that could constitute an acquisition proposal from a person other than Simon, and were permitted to ultimately terminate the merger agreement to accept a Superior Proposal from such person as long as Taubman complies with certain procedures in the merger agreement, as more fully described under “The Merger Agreement—The ‘Go-Shop’ Period”;
|
•
|
that the merger agreement permits the Special Committee, under certain circumstances, to change, withhold, withdraw, qualify or modify its recommendation and permits Taubman under certain circumstances to respond to inquiries regarding acquisition proposals and, upon payment of a termination fee of either $46,604,909 (if the merger agreement had been terminated during the go-shop period or in certain circumstances for a limited time period thereafter) or $111,851,783 (if the merger agreement is terminated following such periods) to Simon, to terminate the merger agreement to accept a Superior Proposal (as such term is defined in the merger agreement), as described under the section entitled “The Merger Agreement—The ‘No-Shop’ Period” and “The Merger Agreement—Termination Fees”;
|
•
|
that the Taubman family members are receiving the same consideration as the unaffiliated Taubman shareholders with respect to (i) all shares of Taubman common stock held by the Taubman family members (all of which are being sold in the Transactions), (ii) all shares of Taubman Series B preferred stock held by the Taubman family members (all of which are being sold in the Transactions) and (iii) the Taubman OP units that are being sold by the Taubman family members in connection with the closing of the Transactions; and
|
•
|
that the Special Committee made its evaluation of the Transactions independent of the Taubman family members and their affiliates, and with knowledge of the interests of the Taubman family members and their affiliates in the Transactions.
|
•
|
the participation in the Transactions by the Taubman family members and their affiliates, and the fact that their interests in the Transactions differ from the other Taubman common shareholders (for more information about these interests, refer to the section entitled “—Interests of Taubman’s Directors and Executive Officers in the Transactions”);
|
•
|
the fact that the consideration to be paid in connection with the Transactions of $52.50 per share of Taubman common stock represents:
|
○
|
an implied discount of 3.3% to the highest trading price for the shares of Taubman common stock of $54.30 over the 52-week period ended February 7, 2020, the last completed trading day before the date of the announcement of the Transactions; and
|
○
|
a reduction of $0.50 per share compared to Simon’s initial proposal on November 15, 2019, and a reduction of $7.50 per share compared to the highest price proposed by Simon during the course of negotiations with Taubman, and that such changes were accompanied by a shift from a consideration mix of 25% stock consideration and 75% cash consideration to 100% cash consideration;
|
•
|
the potential impact of the Taubman family members’ existing ownership in Taubman and the Taubman operating partnership on other potential bidders;
|
•
|
the fact that the Special Committee did not conduct a formal pre-signing market check prior to signing the merger agreement;
|
•
|
the risk of Taubman incurring substantial expenses related to the Transactions, including in connection with any litigation that may result;
|
•
|
the merger agreement’s restrictions on the conduct of Taubman’s and its subsidiaries’ business prior to the completion of the Transactions, generally requiring Taubman and its subsidiaries to conduct their business only in the ordinary course, subject to specific limitations, which may delay or prevent Taubman and its subsidiaries from undertaking business opportunities that may arise pending completion of the Transactions;
|
•
|
the risk that the announcement and pendency of the Transactions may cause substantial harm to Taubman’s business or its relationships with employees or tenants or other business relationships and may divert management and employee attention away from the day-to-day operation of Taubman’s business;
|
•
|
the fact that the unaffiliated Taubman shareholders will not have the opportunity to continue participating in Taubman’s potential upside as a standalone company but that the Taubman family will;
|
•
|
that the exchange ratio with respect to the exchange of Taubman OP units for Simon OP units in the Transactions is fixed and will not be adjusted for fluctuations in the market price of Simon common stock and, because Simon OP units are convertible into shares of Simon common stock, the holders of Taubman OP units receiving Simon OP units in the Transactions will be impacted by any decrease in the trading price of Simon common stock between the announcement and the closing of the Transactions;
|
•
|
that the receipt of cash in respect of shares of Taubman common stock in the Transactions will be taxable to Taubman common shareholders for U.S. federal income tax purposes (for more information about these tax matters, refer to the section entitled “—Material U.S. Federal Income Tax Consequences of the REIT Merger”);
|
•
|
that, under specified circumstances, the Taubman operating partnership may be required to pay a termination fee in the event the merger agreement is terminated and the effect this could have on Taubman and its subsidiaries, including:
|
○
|
the possibility that the termination fee could discourage other potential parties from making a competing offer, although the Special Committee and the Taubman Board both believed that the sizes of the termination fees, representing approximately 1.0% of the total equity value of Taubman (or 1.25% of the total equity value of Taubman and its subsidiaries to be acquired by Simon in the Transactions) based on the consideration of $52.50 per share of Taubman common stock if the merger agreement is terminated during the go-shop period or in certain circumstances for a limited time period thereafter or approximately 2.4% of the total equity value of Taubman (or 3% of the total equity value of Taubman and its subsidiaries to be acquired by Simon in the Transactions) based on the consideration of $52.50 per share of Taubman common stock if the merger agreement is terminated following the conclusion of such periods, were reasonable in amount and would not unduly deter any other party that might be interested in making a competing proposal; and
|
○
|
if the merger is not consummated, Taubman may be required to pay its own expenses associated with the Transactions;
|
•
|
the fact that there can be no assurance that all conditions to the parties’ obligations to complete the Transactions will be satisfied and that, as a result, it is possible that the Transactions may not be completed even if the merger agreement is adopted and the requisite shareholder approval is obtained;
|
•
|
the risks and costs to Taubman if the Transactions do not close, including the diversion of management and employee attention, potential employee attrition and the potential effect on business and tenant relationships;
|
•
|
that certain Taubman directors and officers may have interests in the Transactions that may be different from, or in addition to, those of the other Taubman shareholders (for more information about these interests, refer to the section entitled “—Interests of Taubman’s Directors and Executive Officers in the Transactions”);
|
•
|
the risks and costs to Taubman in connection with potential litigation relating to the Transactions; and
|
•
|
risks of the type and nature described under the sections titled “Cautionary Statement Concerning Forward-Looking Information.”
|
•
|
Reviewed the financial terms and conditions of the merger agreement;
|
•
|
Reviewed certain publicly available historical business and financial information relating to Taubman;
|
•
|
Reviewed various financial forecasts and other data provided to Lazard by Taubman relating to the business of Taubman (including the Projections);
|
•
|
Held discussions with members of the senior management of Taubman with respect to the business and prospects of Taubman;
|
•
|
Reviewed public information with respect to certain other companies in lines of business Lazard believed to be generally relevant in evaluating the business of Taubman;
|
•
|
Reviewed historical stock prices and trading volumes of Taubman common stock; and
|
•
|
Conducted such other financial studies, analyses and investigations as Lazard deemed appropriate.
|
•
|
the estimated future cash flows that Taubman is expected to generate for each of fiscal years 2020 through 2023; and
|
•
|
the estimated value of Taubman at the end of fiscal year 2023 or the terminal value.
|
|
| |
Taubman
|
| |
Select Comparable
Companies |
As of February 7, 2020*
|
| |
7.1%
|
| |
7.2%
|
As of January 31, 2020**
|
| |
7.7%
|
| |
7.4%
|
1-Year Average
|
| |
6.6%
|
| |
6.6%
|
3-Year Average
|
| |
5.9%
|
| |
6.2%
|
5-Year Average
|
| |
5.5%
|
| |
5.7%
|
*
|
The last trading day before the announcement of the Transactions.
|
**
|
The last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman.
|
Implied Price Per Share Range
|
$43.84 – $65.28
|
|
| |
Taubman
|
| |
Select Comparable
Companies |
As of February 7, 2020*
|
| |
9.4x
|
| |
8.9x
|
As of January 31, 2020**
|
| |
7.2x
|
| |
8.4x
|
1-Year Average
|
| |
11.1x
|
| |
11.0x
|
3-Year Average
|
| |
13.8x
|
| |
13.0x
|
5-Year Average
|
| |
16.2x
|
| |
15.2x
|
*
|
The last trading day before the announcement of the Transactions.
|
**
|
The last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman.
|
|
| |
Implied Price Per Share Range
|
Current 2020 FFO*
|
| |
$23.34-$37.94
|
2020 FFO 1-Year Average
|
| |
$32.88-$47.47
|
2020 FFO 3-Year Average
|
| |
$40.21-$54.81
|
*
|
As of January 31, 2020, the last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman.
|
Announcement Date
|
| |
Target / Acquiror
|
| |
Capitalization Rate
|
03/26/18
|
| |
General Growth Properties / Brookfield Property Partners L.P.
|
| |
5.7%
|
09/16/14
|
| |
Glimcher Realty Trust / Washington Prime Group, Inc.
|
| |
5.8%
|
|
| |
Mean
|
| |
5.8%
|
|
| |
Median
|
| |
5.8%
|
Implied Per Share Equity
Value Reference Range |
$47.41 – $67.17
|
|
| |
Premia to Share Price on
Undisturbed Date |
75th Percentile
|
| |
22.4%
|
25th Percentile
|
| |
13.1%
|
•
|
if Taubman can successfully execute its business strategy, the value of Simon’s equity investment could increase;
|
•
|
the Transactions could provide Taubman with greater operational flexibility than it would have had as an independent public company; and
|
•
|
ceasing to be a public entity would free Taubman from reporting and other substantial burdens placed on public entities.
|
•
|
the Special Committee, composed of non-management independent directors who are not affiliated with Taubman, determined, by unanimous vote of all of the members of the Special Committee, and the Taubman Board determined, by the unanimous vote of all members of the Taubman Board that the Transactions are fair to, and in the best interests of, Taubman’s unaffiliated security holders;
|
•
|
the Special Committee retained independent, nationally recognized legal and financial advisors, each of which has extensive experience in transactions similar to the REIT Merger;
|
•
|
the common stock merger consideration of $52.50 per share in cash represents an implied premium of 51.4% to the closing share price for Taubman common stock of $34.67 on February 7, 2020, the last completed trading day before the announcement of the Transactions;
|
•
|
the $52.50 per share common stock merger consideration and other terms and conditions of the merger agreement resulted from extensive negotiations between the Special Committee and its advisors and the Simon parties and their advisors;
|
•
|
the Special Committee received an opinion, dated February 9, 2020, from its financial advisor as to the fairness, from a financial point of view and as of such date, of the common stock merger consideration to be received by holders of Taubman’s unaffiliated security holders pursuant to the merger agreement, which opinion was based upon and subject to various assumptions made, procedures followed, factors considered and limitations on the review undertaken;
|
•
|
the merger agreement allows the Taubman Board, acting upon the recommendation of the Special Committee, to withdraw its recommendation of the merger agreement in favor of the Mergers in response to a Superior Proposal or intervening event, subject to Taubman paying Simon a termination fee of $46,604,909 (if the merger agreement had been terminated during the go-shop period or in certain circumstances for a limited time period thereafter) or $111,851,783 (if the merger agreement is terminated following the conclusion of such periods) to Simon if (i) Taubman terminates the merger agreement in connection with a Superior Proposal, (ii) Simon terminates the merger agreement in connection with a Taubman Board recommendation change or (iii) under specified circumstances, Taubman enters into a competing proposal within twelve months following a termination of the merger agreement; and
|
•
|
the merger agreement is subject to the approval and adoption by (i) the affirmative vote of the holders of at least two-thirds of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class), (ii) the affirmative vote of the holders of a majority of the outstanding shares of Taubman Series B preferred stock and (iii) the affirmative vote of the holders of at least a majority of the outstanding shares of Taubman voting stock entitled to vote thereon (voting together as a single class) excluding the outstanding shares of Taubman voting stock owned of record or beneficially by the Taubman family members.
|
•
|
the risk that the REIT Merger might not be completed in a timely manner or at all; and
|
•
|
the fact that the merger agreement provides that, during the period from the date 45 days following the execution of the merger agreement until the effective time of the REIT Merger, Taubman is subject to certain restrictions on its ability to solicit alternative acquisition proposals from third parties and to provide non-public information to third parties and to engage in negotiations with third parties regarding alternative acquisition proposals, subject to customary exceptions.
|
•
|
the Special Committee unanimously determined that the merger agreement and the Transactions are advisable and fair to, and in the best interests of, Taubman and the Taubman common shareholders;
|
•
|
the Taubman Board, based on the recommendation of the Special Committee, unanimously determined that the merger agreement and the Transactions are advisable and fair to, and in the best interests of, Taubman and the Taubman common shareholders;
|
•
|
the common stock merger consideration of $52.50 per share in cash represents an implied premium of 98.7% to the closing share price for Taubman common stock of $26.42 on January 31, 2020, the last trading day prior to market rumors emerging that Simon was engaging in discussions to acquire Taubman, and an implied premium of 51.4% to the closing share price for Taubman common stock of $34.67 on February 7, 2020, the last completed trading day before the announcement of the Transactions;
|
•
|
the common stock merger consideration payable to the Taubman shareholders, and the other terms and conditions of the merger agreement, resulted from negotiations between and among Taubman, the Special Committee, the Taubman family members, the Simon parties and each of their respective advisors;
|
•
|
notwithstanding that the opinion of Lazard was provided for the information and assistance of the Special Committee and that none of the Taubman filing persons and the Simon parties are entitled to rely on (or relied on) such opinion, the fact that the Special Committee received the opinion of Lazard, dated February 9, 2020, to the effect that, as of February 9, 2020, and based on and subject to the factors and assumptions set forth in the written opinion of Lazard, the consideration to be paid to the Taubman shareholders (other than the Simon parties, the Taubman family members and any of their respective affiliates) pursuant to the merger agreement was fair from a financial point of view to such holders, as further described under “—Opinion of Financial Advisor to the Special Committee”;
|
•
|
the Special Committee retained and was advised by its own legal and financial advisors, each of which has extensive experience in transactions similar to the Transactions;
|
•
|
the Special Committee was involved in frequent and extensive deliberations over a period of more than three months regarding Simon’s proposal to acquire Taubman and the other transactions contemplated by the merger agreement, including 32 Special Committee meetings, and was provided with full access to Taubman management and its advisors in connection with its evaluation process;
|
•
|
the belief that the value to Taubman shareholders of Taubman continuing as an independent public company would not be as great as the common stock merger consideration;
|
•
|
the common stock merger consideration provides Taubman shareholders with immediate certainty of greater value and liquidity at an attractive per share equity value without the market or execution risks associated with continued independence as a public company;
|
•
|
the Special Committee’s belief that the common stock merger consideration to be paid in the Transactions represented the highest per share consideration that could be obtained;
|
•
|
the approval and adoption of the merger agreement is subject to a “majority-of-the-minority” voting requirement, pursuant to which the consummation of the Transactions is subject to a condition that the merger agreement be adopted by the affirmative vote of holders of a majority of the outstanding shares of Taubman voting not beneficially owned by the Taubman family members;
|
•
|
the Taubman Board agreed not to approve a transaction or any alternative thereto without a prior favorable recommendation with respect to such transaction or alternative by the Special Committee;
|
•
|
the Taubman family members are receiving the same consideration as the unaffiliated Taubman shareholders with respect to all shares of the Taubman common stock held by the Taubman family members (all of which are being sold in the Transactions);
|
•
|
the merger agreement provides for a “go-shop” period, during which the Special Committee and its advisors may solicit, initiate, propose or induce the making, submission or announcement of, or encourage, facilitate or assist, any proposal or offer that could constitute an acquisition proposal from a person other than the Simon parties, and may ultimately terminate the merger agreement to accept a Superior Proposal from such person as long as Taubman complies with certain procedures in the merger agreement, as more fully described under “The Merger Agreement—The ‘Go-Shop’ Period”;
|
•
|
the merger agreement permits the Special Committee, under certain circumstances, to change, withhold, withdraw, qualify or modify its recommendation and permits Taubman under certain circumstances to respond to inquiries regarding acquisition proposals and, upon payment of a termination fee to Simon of either $46,604,909 (if the merger agreement had been terminated during the go-shop period or in certain circumstances for a limited time period thereafter) or $111,851,783 (if the merger agreement is terminated
|
•
|
the Taubman family members have agreed to negotiate in good faith with a competing bidder that has made a proposal that the Special Committee determines is a Superior Proposal, or is reasonably likely to lead to a Superior Proposal, and that has a structure similar to the Transactions, and the Taubman family members have agreed to discuss in good faith with the Special Committee terms on which the Taubman family members might be willing to agree to an alternative transaction that does not have a structure similar to the Transactions; and
|
•
|
the Special Committee had considered alternatives, including continuing to operate Taubman on a standalone basis, a sale of selected assets, a spin-off of selected assets or a sale to an alternative buyer, and considered the risks and uncertainties associated with such alternatives, and the Special Committee concluded that no other alternatives were reasonably likely to create greater value for the unaffiliated holders of Taubman common stock than the Transactions.
|
•
|
NOI growth is based on, where applicable, specific redevelopment plans for each property, and it is otherwise based on assumed same property growth rates ranging from -2.0% to 4.0% per annum, based on the assessed growth potential of the properties. The growth potential of each property is evaluated based on various factors including, but not limited to, the location of the property, foot traffic, competitive positioning, upcoming supply and tenant demand. Property revenues and expenses are estimated based on a stabilized occupancy rate, forward lease expirations, tenant sales projections (which are based on historical and expected tenant performance), releasing and renewal rental rates (which are based on recently signed rents, tenant feedback and historical and expected occupancy cost ratios) and historical and projected expense margins and cost reimbursement from tenants. The properties are categorized into four distinct groups, each with a different assumed same property growth rate, based on their assessed potential and projected performance.
|
•
|
Straight-line adjustments to rental revenues for 2021 through 2024 at each property are based on the average of the actual straight-line adjustments recognized in 2018 and 2019 and the estimated straight-line adjustments in 2020.
|
•
|
Beneficial interest in total lease cancellation income across all properties will normalize from approximately $10 million in 2020 to approximately $5 million in 2024.
|
•
|
Straight-line of ground rent expense for 2020 through 2024 will remain flat, based on 2019 actual amount of $1.5 million per annum.
|
•
|
Non-real estate depreciation will remain flat, based on 2020 estimate of $4.5 million per annum.
|
•
|
Stamford Town Center is sold in 2020.
|
•
|
Proceeds from the sale of 50% of Taubman’s interest in CityOn.Xi’an to Blackstone are received in 2020.
|
•
|
General and administrative expenses relating to corporate overhead in the U.S., and other operating expenses related to corporate overhead in Asia will grow at a rate of 2.0% per annum, based on the 2020 estimated amount.
|
•
|
Pre-construction development costs, fees associated with management, leasing and development services, and other corporate income and expenses will remain constant after 2020 estimated amount.
|
•
|
Share-based compensation expense will remain at approximately $11 million per year, in line with historical averages of the actual share-based compensation expenses for the years ended December 31, 2016, 2017 and 2018.
|
•
|
Mortgages will be refinanced at their respective maturities in-line with existing debt yields and cost of debt. Interest expense from term loans and credit facilities are projected based on existing swap arrangements and contractual spreads to monthly one-month forward LIBOR, and includes a 25 bps cushion.
|
•
|
Available free cash flow in excess of an assumed minimum cash balance outside of Asia at the end of each year will be used to repay existing indebtedness.
|
•
|
The Taubman Series J Preferred Stock and Taubman Series K Preferred Stock will remain in place.
|
•
|
Common area maintenance capital expenses, leasing capital expenses and development and renovation capital expenditures for each property for 2020 to 2024 are estimated based on historical and expected capital spending and take into account specific redevelopment plans for each property.
|
•
|
No equity issuances will occur other than in connection with share-based compensation.
|
•
|
No dividend growth through the period.
|
|
| |
For the Year Ending December 31,
|
||||||||||||
($ in millions, except for per share amounts)
|
| |
2020
|
| |
2021
|
| |
2022
|
| |
2023
|
| |
2024
|
Beneficial interest in Property NOI(1)
|
| |
$582.7
|
| |
$607.2
|
| |
$627.6
|
| |
$643.9
|
| |
$660.3
|
Beneficial interest in EBITDA(2)
|
| |
$552.2
|
| |
$572.7
|
| |
$590.9
|
| |
$605.1
|
| |
$619.5
|
Interest Expense
|
| |
$(197.0)
|
| |
$(209.9)
|
| |
$(217.0)
|
| |
$(227.4)
|
| |
$(224.9)
|
Adjusted FFO(3)
|
| |
$324.0
|
| |
$331.7
|
| |
$342.6
|
| |
$346.2
|
| |
$363.0
|
Adjusted FFO Per Diluted Share(4)
|
| |
$3.65
|
| |
$3.73
|
| |
$3.85
|
| |
$3.88
|
| |
$4.06
|
Unlevered Free Cash Flow(5)
|
| |
$277.2
|
| |
$412.1
|
| |
$458.8
|
| |
$498.9
|
| |
$560.1
|
(1)
|
Beneficial interest in Property NOI is defined as property-level operating revenue (excluding straight-line adjustments to rental revenue), less maintenance, property taxes, utilities, promotion, ground rent, other property operating expenses, and lease cancellation income.
|
(2)
|
Beneficial interest in EBITDA represents the Taubman operating partnership’s share of earnings before interest, income taxes, and depreciation and amortization of the consolidated and unconsolidated businesses.
|
(3)
|
Adjusted FFO is defined as FFO as defined by the National Association of Real Estate Investments Trusts (NAREIT FFO) excluding certain non-recurring items including, but not limited to, restructuring charges, deferred income tax expense, costs associated with shareholder activism, charges recognized in connection with the write-off of deferred financings costs, promote fees, and fluctuation in the fair value of equity securities.
|
(4)
|
Adjusted FFO Per Diluted Share is calculated as Adjusted FFO divided by the projected number of weighted average shares outstanding, as adjusted for the dilutive impact of share-based compensation ((i) 88,778,702 shares outstanding as of 2020, (ii) 88,851,190 shares outstanding as of 2021, (iii) 89,058,463 shares outstanding as of 2022, (iv) 89,284,430 shares outstanding as of 2023 and (v) 89,502,217 shares outstanding as of 2024).
|
(5)
|
Unlevered Free Cash Flow is defined as Beneficial interest in EBITDA, plus straight-line rent adjustments, plus straight-line of ground leases, plus share-based compensation, plus net proceeds from dispositions, less taxes, less capital expenditures.
|
Name
|
| |
TCO RSUs
(#) |
| |
TCO PSUs
(#)(a) |
| |
Time-Vesting
Taubman Incentive Units (#) |
| |
Performance-
Vesting Taubman Incentive Units (#)(a) |
| |
TCO DERs
($) |
Robert S. Taubman
Chief Executive Officer |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Simon J. Leopold
EVP, Chief Financial Officer & Treasurer |
| |
18,399
|
| |
22,460
|
| |
8,154
|
| |
36,690
|
| |
68,536.13
|
William S. Taubman
Chief Operating Officer |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Paul A. Wright
President, Taubman Asia |
| |
18,772
|
| |
18,592
|
| |
—
|
| |
—
|
| |
113,510.08
|
Peter J. Sharp
President, Taubman Asia |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
(a)
|
TCO PSUs and performance-vesting Taubman Incentive Units are granted (and therefore outstanding) assuming the maximum number of shares or units, as applicable, that are eligible to become vested. If performance achievement does not result in the maximum number of shares or units being vested, any then unvested portion of the shares or units are forfeited.
|
Name
|
| |
Number of TCO
DSUs (#) |
| |
Amount Payable at
Closing(1) ($) |
Mayree Clark
|
| |
—
|
| |
—
|
Michael J. Embler
|
| |
7,036
|
| |
369,390
|
Janice L. Fields
|
| |
7,352
|
| |
385,980
|
Michelle J. Goldberg
|
| |
5,245
|
| |
275,363
|
Nancy Killefer
|
| |
4,818
|
| |
252,945
|
Cia Buckley Marakovits
|
| |
15,544
|
| |
816,060
|
Ronald W. Tysoe
|
| |
29,767
|
| |
1,562,768
|
Myron E. Ullman, III
|
| |
20,759
|
| |
1,089,846
|
(1)
|
Amounts are calculated by multiplying (a) the common stock merger consideration price of $52.50 per share, times (b) the number of shares of Taubman common stock subject to the TCO DSUs held by each of the non-employee directors as of April 1, 2020, the assumed closing date of the Transactions.
|
•
|
the amounts noted above for termination by reason of death or disability;
|
•
|
two and a half times the executive’s annual base salary and an annual cash bonus amount;
|
•
|
continued welfare benefits and perquisites for at least thirty months; and
|
•
|
outplacement services for one year.
|
(i)
|
payment of annual salary and (if any) unused paid time off or unused vacation earned and accrued prior to such termination (paid no more than 30 days after termination);
|
(ii)
|
a cash lump sum payment (payable within 65 days after termination) equal to the sum of: (A) 250% of the sum of (x) 12 times the highest monthly base salary in the 12-month period preceding the month in which termination occurs (“Annual Base Salary”) and (y) the greater of the Participant’s target bonus in the year of termination or the highest bonus earned in the last three full fiscal years (or for such lesser number of full fiscal years prior to termination), including annualization for a bonus earned in a partial fiscal year plus (B) 18 times the applicable monthly COBRA premium;
|
(iii)
|
full and immediate vesting of the Participant’s unvested equity awards (other than performance equity awards) granted under the applicable Taubman Stock Plan prior to 2019; and
|
(iv)
|
the vesting of the Participant’s unvested performance equity awards granted under the applicable Taubman Stock Plan prior to 2019, with the determination of performance and other factors as provided under the terms of such plan and related award agreements.
|
•
|
The relevant price per share of Taubman common stock is $52.50 (see “Background of the Transactions” for more information as to how this price per share was determined);
|
•
|
The effective time of the Transactions is April 1, 2020, which is the assumed date of the closing of the Transactions solely for purposes of the disclosure in this section;
|
•
|
For purposes of determining the amount payable in respect of TCO PSUs, the target performance was used;
|
•
|
The employment of each executive officer of Taubman was terminated by Taubman without “cause” or due to the officer’s resignation for “good reason” (as such terms are defined in the relevant plans and agreements), in either case, immediately following the assumed effective time of April 1, 2020;
|
•
|
The number of outstanding Taubman Equity Awards and the compensation and benefits levels used in the calculations below reflect levels in effect on April 1, 2020, which may change based on when the effective time of the Transactions occurs; and
|
•
|
Although this disclosure provides information for each of our named executive officers, all references to “TCO NEOs” used below refer solely to Messrs. Leopold and Wright.
|
Name
|
| |
Cash ($)(1)
|
| |
Equity ($)(2)
|
| |
Perquisites/
Benefits ($)(3) |
| |
Tax
Reimbursement ($) |
| |
Total ($)
|
R. Taubman
Chief Executive Officer |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Simon Leopold
EVP, Chief Financial Officer & Treasurer |
| |
3,136,875
|
| |
2,190,372
|
| |
116,916
|
| |
—
|
| |
|
W. Taubman
Chief Operating Officer |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Paul A. Wright
President, Taubman Asia |
| |
2,026,417
|
| |
2,075,120
|
| |
10,101
|
| |
—
|
| |
|
Peter J. Sharp
President, Taubman Asia(4) |
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
(1)
|
Cash. On a Severance Plan CIC Termination, Mr. Leopold is entitled to a lump sum cash payment equal to (a) 250% of the sum of (x) his annual base salary ($525,000) and (y) the annual cash bonus amount determined as provided in his change of control employment agreement (which for purposes of the table above, is assumed to be equal to Mr. Leopold’s annual cash bonus earned in respect of 2018, equal to 129% of his base salary ($677,250)), which is equal to $3,005,625 and (b) a prorated portion of his annual bonus for the year of termination, which for purposes of the table above, is calculated assuming achievement of target performance, and equal to $131,250 (i.e., 3/12 of 100% of his $525,000 annual base salary). On a Severance Plan CIC Termination, Mr. Wright is entitled to severance benefits equal to the following: (1) a lump sum cash payment equal to 250% of the sum of (x) his Annual Base Salary ($502,577) and (y) the annual cash bonus amount determined as provided in the Severance Plan (which for purposes of the table above, is assumed to be equal to Mr. Wright’s target annual cash bonus opportunity, equal to $257,732) which is equal to $1,900,773, and (2) three months base salary ($125,644) per his employment terms. Note that for Mr. Wright, all amounts have been converted from Hong Kong dollars to U.S. dollars based on the exchange rate of HKD:USD of 7.76:1.
|
Equity Awards. On the Stock Plan CIC Termination date, each TCO NEO becomes fully vested in unvested TCO RSUs and TCO PSUs (and related TCO DERs) that “single trigger” vest on the closing of the Transactions, and also in those unvested cash substitute awards into which TCO RSUs and TCO PSUs were converted on the closing of the Transactions, and related TCO DERs, which “double trigger” vest on the Stock Plan CIC Termination. The amounts in the table below reflect the value of the TCO RSUs, TCO PSUs and TCO DERs that become vested, in accordance with their terms, on the Stock Plan CIC Termination Date. Note that for Mr. Leopold, the amounts in the table below also reflect those time-vesting and performance-vesting Taubman Incentive Units which “single trigger” vest on the closing of the Transactions and “double trigger” vest on the Stock Plan CIC Termination.
|
|
| |
Single Trigger Vesting ($)
|
| |
Double Trigger Vesting ($)
|
||||||||||||
|
| |
|
| |
Cash Substitute Awards
|
||||||||||||
Named Executive Officer
|
| |
TCO
RSUs(a) |
| |
TCO
PSUs(a) |
| |
TCO
DERs(a) |
| |
TCO
RSUs(b) |
| |
TCO
PSUs(b) |
| |
TCO
DERs(b) |
R. Taubman
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Mr. Leopold
|
| |
423,098
|
| |
634,620
|
| |
—
|
| |
426,458
|
| |
639,660
|
| |
68,536
|
W. Taubman
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Mr. Wright
|
| |
306,285
|
| |
301,875
|
| |
69,446
|
| |
679,245
|
| |
674,205
|
| |
44,064
|
Mr. Sharp
|
| |
|
| |
|
| |
—
|
| |
|
| |
|
| |
—
|
(a)
|
Of these “single trigger” vesting TCO RSUs, TCO PSUs and Taubman Incentive Units, as applicable, this number reflects: (i) for Mr. Wright, 5,834 of TCO RSUs having a value of $306,285 and for Mr. Leopold, 8,059 of Taubman Incentive Units having a value of $423,098, in each case that would otherwise have vested subject to continued service; and (ii) for Mr. Wright, 5,750 of TCO PSUs having a value of $301,875 and for Mr. Leopold, 12,088 of Taubman Incentive Units having a value of $634,620, in each case that otherwise vested subject to performance-vesting (which are becoming vested based on the greater of the average of actual performance achievement of the two performance metrics applicable to such grants, as of the closing, and target performance). In each case, the value of the TCO RSUs, TCO PSUs and Taubman Incentive Units has been determined by multiplying the number of awards by the common stock merger consideration price of $52.50 per share. Of these “single trigger” TCO DERs, this number reflects for Mr. Wright, $34,975 accrued in respect of the “single trigger” TCO RSUs, and $34,471 accrued in respect of the “single trigger” TCO PSUs, in each case to which his TCO DERs relate, as applicable.
|
(b)
|
Of these “double trigger” vesting TCO RSUs, TCO PSUs and Taubman Incentive Units, as applicable, this number reflects: (i) for Mr. Wright, 12,938 of TCO RSUs having a value of $679,245 and for Mr. Leopold, 8,123 of TCO RSUs having a value of $426,458 in each case that, once converted into cash substitute awards, would otherwise have continued to vest subject to continued service; (ii) for Mr. Wright, 12,842 of TCO PSUs having a value of $674,205 and for Mr. Leopold, 12,184 of Taubman Incentive Units having a value of $639,660, in each case that, once converted into cash substitute awards, would otherwise vest subject to performance-vesting (which are becoming vested based on the greater of the average of actual performance achievement of the two performance metrics applicable to such grants, as of the closing, and target performance). In each case, the value has been determined by multiplying the number of awards by the common stock merger consideration price of $52.50 per share. Of these “double trigger” TCO DERs, this number reflects: (x) for Mr. Wright, $22,194 accrued in respect of the “double trigger” TCO RSUs, and $21,870 accrued in respect of the “double trigger” TCO PSUs, in each case to which his TCO DERs relate, as applicable; and (y) for Mr. Leopold, $27,415 accrued in respect of the “double trigger” TCO RSUs, and $41,121 accrued in respect of the “double trigger” TCO PSUs, in each case to which his TCO DERs relate, as applicable.
|
(3)
|
Perquisites/Benefits. Messrs. Leopold and Wright are entitled to the following “double trigger” severance benefits upon a termination without cause or resignation with good reason during the three years (for Mr. Leopold) or one year (for Mr. Wright) following the change in control of Taubman: (a) for Mr. Leopold, continued provision of welfare benefits (inclusive of medical, prescription, dental, short-term and long-term disability, employee life, group life, accidental death and travel accident insurance) for 30 months having a value (using 2020 COBRA rates) equal to $107,916 and one year of outplacement services having a value of $9,000, and (b) for Mr. Wright, three months of continued health care, having a value of $10,100.
|
(4)
|
Mr. Sharp ceased to be employed with Taubman on October 9, 2019. Consequently, he is not entitled to any golden parachute compensation.
|
Description
|
| |
Amount
(in thousands) |
Financial advisors fee and expenses
|
| |
$[•]
|
Legal fees and expenses
|
| |
$[•]
|
Accounting fees and expenses
|
| |
$[•]
|
SEC filing fee
|
| |
$[•]
|
Printing, proxy solicitation, filing fees and mailing costs
|
| |
$[•]
|
Miscellaneous
|
| |
$[•]
|
Total fees and expenses
|
| |
$[•]
|
•
|
the Merger Agreement Proposal;
|
•
|
the Advisory Compensation Proposal; and
|
•
|
the Adjournment Proposal.
|
•
|
“FOR” the Merger Agreement Proposal;
|
•
|
“FOR” the Advisory Compensation Proposal; and
|
•
|
“FOR” the Adjournment Proposal.
|
•
|
submitting a new proxy with a later date, including as described above by Internet proxy submission, using the telephone or by completing, signing, dating and returning a new proxy card by mail to the Company;
|
•
|
attending the special meeting and voting in person; or
|
•
|
giving written notice of revocation to the Secretary of the Company, Chris Heaphy, Taubman Centers, Inc., 200 East Long Lake Road, Suite 300, P.O. Box 200, Bloomfield Hills, Michigan 48303-2324, or by giving written notice of revocation in person at the special meeting.
|
•
|
each Taubman OP unit issued and outstanding immediately prior to the effective time of the Partnership Merger held by a minority partner will be converted into the right to receive, at the election of such minority partner, the common stock merger consideration or 0.3814 new Simon OP units;
|
•
|
certain Taubman OP units issued and outstanding immediately prior to the effective time of the Partnership Merger held by a Taubman family member will remain outstanding as units of partnership interest in the Surviving Taubman operating partnership; and
|
•
|
all other Taubman OP units issued and outstanding immediately prior to the effective time of the Partnership Merger held by a Taubman family member will be converted into the right to receive the common stock merger consideration.
|
•
|
each share of Taubman common stock issued and outstanding immediately prior to the effective time of the REIT Merger will be converted into the right to receive the common stock merger consideration; and
|
•
|
each share of Taubman Series B preferred stock will be converted into the right to receive an amount in cash equal to the common stock merger consideration divided by 14,000.
|
•
|
each outstanding Taubman RSU and each outstanding Taubman PSU granted under the Taubman Stock Plans that vests in accordance with its terms in connection with the effective time of the REIT Merger will automatically convert into the right to receive the common stock merger consideration (with the number of shares of Taubman common stock subject to any such Taubman PSU that will become vested to be based on assumed achievement of performance metrics at the greater of (x) the average of actual performance achievement of the two performance metrics applicable to such grants, as of the closing, and (y) target performance);
|
•
|
each outstanding Taubman RSU and Taubman PSU that is not eligible to vest in accordance with its terms in connection with the effective time of the REIT Merger will be converted into a cash substitute award to be paid (i) with respect to any such award granted prior to 2020, in accordance with the same service-vesting schedule that applied to the original Taubman RSU or Taubman PSU award (with the number of shares of Taubman common stock subject to any such Taubman PSU granted prior to 2020 to be based on assumed achievement of performance metrics at the greater of (x) the average of actual performance achievement of the two performance metrics applicable to such grants, as of the closing, and
|
•
|
each outstanding Taubman DSU granted under the Taubman Stock Plans will be converted into the right to receive the common stock merger consideration; and
|
•
|
each Taubman DER will be treated in the same manner as the outstanding Taubman RSU or Taubman PSU to which such Taubman DER relates. Any such Taubman DER related to a Taubman RSU or Taubman PSU which by its terms does not vest at the effective time of the REIT Merger will convert to a cash substitute award that continues to accrue, at a rate of $0.675 per share, on a quarterly basis over the remaining vesting schedule of the related substitute award and will be paid on the same terms that applied to the original related Taubman RSU or Taubman PSU.
|
•
|
the merger agreement and the Transactions must have been approved and adopted by (i) the affirmative vote of the holders of at least two-thirds of the outstanding shares of Taubman common stock and Taubman Series B preferred stock (voting together as a single class) entitled to vote at the Taubman shareholders meeting, (ii) the affirmative vote of the holders of at least a majority of the outstanding shares of Taubman Series B preferred stock entitled to vote at the Taubman shareholders meeting and (iii) the affirmative vote of the holders of at least a majority of the outstanding shares of Taubman common stock and Taubman Series B preferred stock (voting together as a single class) entitled to vote at the Taubman shareholders meeting (excluding the outstanding shares of Taubman common stock and Taubman Series B preferred stock owned of record or beneficially by the Taubman family members);
|
•
|
the Partnership Merger must have been approved by the written consent of partners (other than Taubman and other than any “Parity Preferred Partner” (as defined in the Taubman OP agreement)) holding at least fifty percent (50%) of the aggregate percentage interests in the Taubman operating partnership held by such partners (the “Taubman operating partnership approval”), and such approval must not have been rescinded, modified or withdrawn;
|
•
|
no applicable law and no judgment, preliminary, temporary or permanent, or other legal restraint or prohibition and no binding order may be in effect, or imminently threatened by any governmental entity of competent jurisdiction, which prohibits, makes illegal, enjoins, or otherwise prevents the consummation of the Transactions; and
|
•
|
the shares of Simon common stock to be reserved for issuance upon exchange or redemption of Simon OP units issued or issuable to holders of Taubman OP units in the Transactions must have been approved for listing on the NYSE, subject to official notice of issuance.
|
•
|
the representations and warranties of Taubman and the Taubman operating partnership relating to qualification, organization and subsidiaries; authority, execution and delivery, and enforceability of the merger agreement; capital structure; and brokers’ fees and expenses must be true and correct in all material respects at and as of the closing date;
|
•
|
the representations and warranties of Taubman and the Taubman operating partnership relating to absence of a material adverse effect (as described below) with respect to Taubman from September 30, 2019 to the date of the merger agreement must be true and correct in all respects at and as of the closing date;
|
•
|
the representations and warranties of Taubman and the Taubman operating partnership relating to capitalization must be true and correct in all respects, except for de minimis inaccuracies, at and as of the closing date;
|
•
|
all other representations and warranties of Taubman and the Taubman operating partnership must be true and correct at and as of the closing date, except where the failure to be true and correct (ignoring for such purposes any reference to materiality or material adverse effect contained in such representations and warranties) would not reasonably be expected to have a material adverse effect (as described below) with respect to Taubman;
|
•
|
Taubman and the Taubman operating partnership must have performed in all material respects all covenants set forth in the merger agreement required to be performed by them under the merger agreement at or prior to the closing date;
|
•
|
since the date of the merger agreement, there must not have occurred and be continuing any material adverse effect with respect to Taubman;
|
•
|
Taubman must have delivered to Simon an officer’s certificate confirming that the preceding conditions have been satisfied; and
|
•
|
Simon must have received a tax opinion of Honigman LLP, tax counsel to Taubman (or, if Honigman LLP is unable or unwilling to render such opinion, Kirkland & Ellis LLP or another nationally recognized REIT counsel as may be reasonably acceptable to Simon), dated as of the closing date, to the effect that, subject to customary exceptions, assumptions and qualifications, at all times since its taxable year ended December 31, 2012 and through and including its taxable year that ends at the effective time of the REIT Merger, Taubman has been organized and operated in conformity with the requirements for qualification and taxation as a REIT under the Code and its actual method of operation has enabled Taubman to meet, through the effective time of the REIT Merger, the requirements for qualification and taxation as REIT under the Code.
|
•
|
the representations and warranties of the Simon parties relating to qualification, organization and subsidiaries; and authority, execution and delivery, and enforceability of the merger agreement; the Simon operating partnership’s capitalization; and brokers’ fees and expenses must be true and correct in all material respects at and as of the closing date;
|
•
|
all other representations and warranties of the Simon parties must be true and correct at and as of the closing date, except where the failure to be true and correct (ignoring for such purposes any reference to materiality or material adverse effect contained in such representations and warranties) would not reasonably be expected to have a material adverse effect with respect to Simon;
|
•
|
the Simon parties must have performed in all material respects all covenants set forth in the merger agreement required to be performed by them under the merger agreement at or prior to the closing date; and
|
•
|
Simon must have delivered to Taubman an officer’s certificate confirming that the preceding conditions have been satisfied.
|
•
|
any direct or indirect acquisition (whether by merger, consolidation or otherwise) of more than 15% of the voting power of Taubman or the Taubman operating partnership by any person or group;
|
•
|
any consolidation, business combination, reorganization, share exchange, sale of assets, recapitalization, equity investment, joint venture, liquidation, dissolution or other similar transaction involving Taubman or the Taubman operating partnership that would result in any person or group, directly or indirectly, acquiring assets (including capital stock of or interests in any subsidiary or affiliate of Taubman) representing, directly or indirectly, more than 15% of the consolidated assets of Taubman and its subsidiaries, taken as a whole (as determined on a book value basis (including indebtedness secured solely by such assets));
|
•
|
any tender offer or exchange offer or any other direct or indirect purchase or other acquisition of securities, that, if consummated, would result in any person or group, whether from Taubman or any other person(s), beneficially owning more than 15% of the outstanding shares of Taubman common stock or more than 15% of the outstanding Taubman OP units;
|
•
|
any other transaction or series of related transactions pursuant to which any person or group proposes to acquire, directly or indirectly, control of assets of Taubman or any of its subsidiaries having a fair market value greater than 15% of the fair market value of all of the assets of Taubman and its subsidiaries, taken as a whole, immediately prior to such transaction; or
|
•
|
any combination of the foregoing.
|
•
|
solicit, initiate or propose the making or submission of, or knowingly encourage or facilitate the making or submission of, any offer or proposal that constitutes or would reasonably be expected to lead to an Acquisition Proposal;
|
•
|
furnish to any person (other than the Simon parties or any of their designees) any non-public information relating to Taubman or any of its subsidiaries or afford to any person (other than the Simon parties or any of their designees) access to the business, properties, assets, books, records or other non-public information, or to any personnel, of Taubman or any of its subsidiaries, in any such case with the intent to induce the making or submission of, or to knowingly encourage, facilitate or assist an Acquisition Proposal;
|
•
|
participate in, knowingly facilitate or engage in discussions or negotiations with any person with respect to an Acquisition Proposal or any offer, proposal or inquiry that would reasonably be expected to lead to an Acquisition Proposal (subject to certain exceptions);
|
•
|
enter into any letter of intent, memorandum of understanding, agreement in principle, investment agreement, merger agreement, acquisition agreement or other contract relating to an Acquisition Transaction or that would reasonably be expected to lead to an Acquisition Proposal, other than an Acceptable Confidentiality Agreement (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract providing for an Acquisition Transaction, an “Alternative Acquisition Agreement”); or
|
•
|
reimburse or agree to reimburse the expenses of any other person (other than Taubman’s or the Taubman operating partnership’s Representatives) in connection with an Acquisition Proposal or any inquiry, discussion, offer or request that would reasonably be expected to lead to an Acquisition Proposal.
|
•
|
withhold, withdraw, amend or modify, or publicly propose to withhold, withdraw, amend or modify, the Taubman Board recommendation (defined as the “Titanium Board Recommendation” in the merger agreement) (in the case of amendments or modifications, in any manner adverse to Simon);
|
•
|
adopt, approve or recommend to the shareholders of Taubman, or publicly propose to adopt, approve or recommend to the shareholders of Taubman, an Acquisition Proposal;
|
•
|
fail to include the Taubman Board recommendation in this proxy statement; or
|
•
|
make any recommendation in connection with a tender offer or exchange offer for the equity securities of Taubman other than a recommendation against such offer, or make any other public statement in connection with such offer that does not expressly reaffirm the Taubman Board recommendation;
|
•
|
the Taubman Board (acting upon the recommendation of the Special Committee) determines in good faith (after consultation with its financial advisor and outside legal counsel) that the failure to do so would be inconsistent with its fiduciary duties pursuant to applicable law;
|
•
|
(i) Taubman has provided prior written notice to Simon at least four business days in advance (the “Notice Period”) to the effect that the Taubman Board (or the Special Committee) has (A) received a Superior Proposal and (B) intends to (x) effect a Taubman Board recommendation change with respect to such Acquisition Proposal or (y) authorize Taubman to terminate the merger agreement to enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal absent any revision to the terms and conditions of the merger agreement, which notice will specify the basis for such actions, including a summary of the material terms and conditions of such Acquisition Proposal and a copy of the definitive proposed transaction agreement and all ancillary agreements and, to the extent containing terms material to such Acquisition Proposal, related schedules (other than any confidential disclosure schedules solely of the person or persons making such Acquisition Proposal), in each case to be entered into in respect of such Acquisition Proposal; and (ii) prior to (x) effecting a Taubman Board recommendation change with respect to such Acquisition Proposal or (y) authorizing Taubman to terminate the merger agreement to enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal, Taubman and its Representatives, during the Notice Period, must have negotiated with Simon and its Representatives in good faith (to the extent that Simon desires to so negotiate) to make such adjustments to the terms and conditions of the merger agreement so that the Taubman Board (or the Special Committee) would no longer determine that the failure to make a Taubman Board recommendation change in response to such Acquisition Proposal would be inconsistent with its fiduciary duties pursuant to applicable law; provided, however, that in the event of any material revisions to such Acquisition Proposal (including any change in price), Taubman will be required to deliver a new written notice to Simon and to comply with the requirements of the merger agreement with respect to such new written notice (it being understood that the “Notice Period” in respect of such new written notice will be three business days); and
|
•
|
in the event of any termination of the merger agreement in order to cause or permit Taubman or any of its subsidiaries to enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal, Taubman has paid (or caused to be paid) the applicable termination fee.
|
•
|
the Taubman Board (acting upon the recommendation of the Special Committee) determines in good faith (after consultation with its financial advisor and outside legal counsel) that the failure to do so would be inconsistent with its fiduciary duties pursuant to applicable law;
|
•
|
Taubman has provided prior written notice to Simon at least four business days in advance to the effect that the Taubman Board (acting upon the recommendation of the Special Committee) has (A) so determined and (B) resolved to effect a Taubman Board recommendation change pursuant to the applicable terms of the merger agreement, which notice will specify and describe the facts and circumstances relating to the applicable Intervening Event in reasonable detail and the factual bases for the Taubman Board’s determination that such events or circumstances constitute an Intervening Event; and
|
•
|
prior to effecting such Taubman Board recommendation change, Taubman and its Representatives, during such four business day period, must have negotiated with Simon and its Representatives in good faith (to the extent that Simon desires to so negotiate) to allow Simon to make such adjustments to the terms and conditions of the merger agreement to obviate the need to effect a Taubman Board recommendation change in response to such Intervening Event, and following such four business day period, the Taubman Board (or the Special Committee) will have determined (after consultation with its financial advisor and outside legal counsel and taking into account Simon’s proposed revisions to the terms and conditions of the merger agreement) in good faith that the failure to make a Taubman Board recommendation change in response to such Intervening Event would be inconsistent with its fiduciary duties pursuant to applicable law; provided,
|
•
|
participate in a reasonable number of meetings, drafting sessions, rating agency presentations and due diligence sessions and assist in preparation of rating agency and other presentations (provided that Taubman and its subsidiaries and their respective Representatives will not be required to participate in more than one road show or similar meeting in respect of marketing third party financing);
|
•
|
furnish Simon and its financing sources with such financial statements, financial data and other information regarding Taubman and its subsidiaries of the type that would be required by Regulation S-X and Regulation S-K promulgated under the Securities Act of 1933, as amended (the “Securities Act”), for a public offering of securities of Simon if Simon were filing a new registration statement, including updates to any such information as may be reasonably requested by Simon;
|
•
|
cause Taubman’s independent accountants to prepare and deliver “comfort letters,” dated the date of each final offering document used in connection with any securities offering by Simon (with appropriate bring-down comfort letters delivered on each closing date of any such offering, including in connection with the exercise of an option to purchase additional securities of Simon), subject to and in compliance with professional standards;
|
•
|
provide customary representation letters to Taubman’s independent accountants in connection with delivery of any such “comfort letters;”
|
•
|
cause Taubman’s independent accountants to provide consent to use of their audit reports in materials relating to such financing in respect of the Transactions, including SEC filings and offering memoranda that include or incorporate Simon’s consolidated financial information and their reports thereon in accordance with normal customary practice; and
|
•
|
provide customary documentation and other information that financing sources reasonably determine is necessary under applicable “know your customer” and anti-money laundering rules and regulations to the extent requested at least ten business days prior to the closing;
|
•
|
by mutual written consent of Taubman and Simon;
|
•
|
if the Transactions have not been completed on or before the end date (however, the right to terminate the merger agreement under this provision will not be available to any party whose failure to fulfill any obligation under the merger agreement (which failure constitutes a breach by such party of the merger agreement) has been the primary cause of, or primarily resulted in, the failure of the Transactions to be consummated on or before such date);
|
•
|
if any governmental entity of competent authority issues a final, non-appealable order or enacts an applicable law that prohibits, makes illegal, enjoins, or otherwise restricts or prevents the consummation of the Transactions (however, the right to terminate the merger agreement under this provision will not be available to any party whose failure to fulfill any obligation under the merger agreement (which failure constitutes a breach by such party of the merger agreement) has been the primary cause of, or primarily resulted in, the failure of the Transactions to be consummated on or before such date); or
|
•
|
if the Taubman shareholders have not approved and adopted the merger agreement at a duly convened meeting of Taubman shareholders.
|
•
|
at any time before the effective time of the REIT Merger, if the Simon parties have breached any representation, warranty or covenant contained in the merger agreement, or if any representation or warranty of the Simon parties has become untrue, in each case, such that, if such breach or failure to be true occurs or continues on the closing date, the conditions to closing relating to the accuracy of the Simon parties’ representations and warranties or the performance by the Simon parties of their covenants under the merger agreement would not be satisfied as of the closing date; however, Taubman may not terminate the merger agreement under this provision unless any such breach or failure to be true (x) is not capable of being cured in a manner sufficient to allow satisfaction of such conditions to closing prior to the end date, or (y) has not been cured prior to the earlier of 45 days after written notice by Taubman to Simon and the end date (however, Taubman may not terminate the merger agreement if Taubman or the Taubman operating partnership is then in breach of any representation, warranty or covenant contained in the merger agreement, or if any representation or warranty of Taubman or the Taubman operating partnership has become untrue, in each case, such that, if such breach or failure to be true occurs or continues on the closing date, the conditions to closing relating to the accuracy of Taubman’s or the Taubman operating partnership’s representations and warranties or the performance by Taubman or the Taubman operating partnership of their covenants under the merger agreement would not be satisfied as of the closing date); or
|
•
|
prior to approval and adoption of the merger agreement by the Taubman shareholders, in order to enter into a definitive written agreement providing for a Superior Proposal in compliance with the “No-Shop” provisions of the merger agreement.
|
•
|
at any time before the effective time of the REIT Merger, if Taubman or the Taubman operating partnership has breached any representation, warranty or covenant contained in the merger agreement (other than the “No-Shop” provisions), or if any representation or warranty of Taubman or the Taubman operating partnership has become untrue, in each case, such that, if such breach or failure to be true occurs or continues on the closing date, the conditions to closing relating to the accuracy of Taubman’s or the Taubman operating partnership’s representations and warranties or the performance by Taubman or the Taubman operating partnership of their covenants under the merger agreement would not be satisfied as of the closing date; however, Simon may not terminate the merger agreement under this provision unless any such breach or failure to be true (x) is not capable of being cured in a manner sufficient to allow satisfaction of such conditions to closing prior to the end date, or (y) has not been cured prior to the earlier of 45 days after written notice by Simon to Taubman and the end date (however, Simon may not terminate the merger agreement if the Simon parties are then in breach of any representation, warranty or covenant contained in the merger agreement, or if any representation or warranty of the Simon parties has become untrue, in each
|
•
|
prior to approval and adoption of the merger agreement by the Taubman shareholders, if a Taubman Board recommendation change has occurred or if Taubman has willfully and materially breached the “No-Shop” provisions of the merger agreement.
|
•
|
if the merger agreement is terminated by Taubman in order to enter into a definitive written agreement providing for a Superior Proposal;
|
•
|
if the merger agreement is terminated by Simon because a Taubman Board recommendation change has occurred or Taubman has willfully and materially breached the “No-Shop” provisions of the merger agreement; or
|
•
|
if (i) an Acquisition Proposal has been made to Taubman and not withdrawn or has been made directly to the shareholders of Taubman generally and not withdrawn, (ii) thereafter the merger agreement is terminated by (x) either Taubman or Simon because the REIT Merger has not been consummated on or before the end date, (y) either Taubman or Simon because the Taubman shareholders have not approved and adopted the merger agreement at a duly convened meeting of Taubman shareholders or (z) Simon because Taubman has breached certain covenants, agreements or other obligations contained in the merger agreement, and (iii) within twelve months of termination such Acquisition Transaction is consummated by Taubman or Taubman enters into a definitive agreement providing for an Acquisition Transaction and such Acquisition Transaction is thereafter consummated by Taubman. For purposes of this termination right, references to the “15%” in the definition of the term “Acquisition Transaction” will be deemed to be references to “50%.”
|
•
|
amend its certificate of incorporation or by-laws, or amend in any manner adverse to Simon or the Simon operating partnership the Taubman OP agreement or the comparable organizational documents of any subsidiary of Taubman;
|
•
|
issue any shares of its capital stock or other equity or voting interests, or redeem, purchase or otherwise acquire any shares of its capital stock or other equity or voting interests;
|
•
|
declare or pay any dividend on or make any other distribution with respect to its capital stock or other equity securities, except for (i) the declaration and payment by Taubman of quarterly dividends, with declaration, record and payment dates consistent with past practice, at a rate not to exceed a quarterly rate of $0.675 per share of Taubman common stock (as well as any prorated dividends for the portion of any quarter in which the closing occurs, which may be declared prior to the closing and have a record and/or payment date immediately prior to closing), (ii) the declaration and payment by Taubman of dividends pursuant to the terms of Taubman’s Series J and Series K Preferred Stock, (iii) the declaration and payment by the Taubman operating partnership of monthly distributions pursuant to the terms of the Taubman OP agreement, with declaration, record and payment dates consistent with past practice, at a rate not to exceed a monthly rate of $0.225 per Taubman OP unit (as well as any prorated distributions for the portion of any month in which the closing occurs, which may be paid immediately prior to closing), and (iv) the declaration and payment of dividends or other distributions to Taubman or the Taubman operating partnership by any direct or indirect subsidiary of Taubman;
|
•
|
prepay, incur or materially amend the terms of any indebtedness, or make loans to, material capital contributions to, or material investments in other persons;
|
•
|
sell, pledge, lease, license, mortgage, guarantee, sell and leaseback, subject to any lien (other than certain permitted liens) or otherwise dispose of any of Taubman’s real properties or interests therein, or any other material properties or material assets;
|
•
|
make or authorize capital expenditures in any calendar year that exceed the amounts budgeted in Taubman’s current capital expenditures plan by more than 5%;
|
•
|
make any material change in its methods or principles of accounting;
|
•
|
assign, transfer, lease, cancel, fail to renew or fail to extend material permits;
|
•
|
settle or compromise any claim or action in excess of specified amounts;
|
•
|
dispose of any material intellectual property owned by or exclusively licensed to Taubman or any of its subsidiaries;
|
•
|
enter into or amend certain contracts;
|
•
|
adopt a plan of merger, liquidation, dissolution, restructuring or other reorganization of Taubman or its non-wholly owned subsidiaries;
|
•
|
cease to maintain its qualification as a REIT;
|
•
|
enter into any tax protection agreement (excluding an amended tax protection agreement); make, change, rescind or revoke any material tax election; change a material method of tax accounting; amend any material tax return; or settle or compromise any material tax liability, audit, claim or assessment; or enter into any closing agreement related to taxes, except in each case to the extent such action is required by applicable law or necessary (A) to preserve the status of Taubman as a REIT or (B) to qualify or preserve the status of any subsidiary of Taubman as a partnership or disregarded entity for federal income tax purposes or as a REIT, a QRS or a TRS under the applicable provisions of Section 856 of the Code;
|
•
|
increase the amount, rate or terms of compensation of any member of Taubman’s operating committee or any executive officer; grant any new equity awards; terminate, promote or hire any member of Taubman’s operating committee; accelerate the vesting or time or payment under any Taubman compensation or benefit plan; or terminate, materially amend or materially increase the benefits provided under any Taubman compensation or benefit plan or enter into or adopt any Taubman compensation or benefit plan;
|
•
|
enter into a collective bargaining agreement;
|
•
|
adopt or implement any stockholder right plan or similar arrangement applicable to the merger agreement or the Transactions;
|
•
|
enter into, amend or terminate any contracts with related parties;
|
•
|
take any action under the Taubman or the Taubman operating partnership organizational documents or otherwise that would give rise to dissenters’, appraisal or similar rights to the holders of Taubman securities with respect to the Transactions;
|
•
|
acquire any corporation or other entity, real property, personal property or material assets in excess of certain limitations; or
|
•
|
authorize or agree to take any of the foregoing actions.
|
•
|
amend the Simon OP agreement solely to the extent such amendment would disproportionately and materially adversely impact the minority partners who elect to receive new Simon OP units in the Partnership Merger as compared to other limited partners of the Simon operating partnership; or
|
•
|
cease to maintain its qualification as a REIT.
|
•
|
corporate organization and similar corporate matters;
|
•
|
approval and authorization of the merger agreement and the Transactions;
|
•
|
capital structure;
|
•
|
required consents and approvals of governmental entities in connection with the Transactions and non-contravention;
|
•
|
information supplied in connection with this proxy statement;
|
•
|
taxes; and
|
•
|
brokers fees and expenses.
|
•
|
documents filed with the SEC and financial statements included in those documents;
|
•
|
absence of certain changes since September 30, 2019;
|
•
|
absence of undisclosed liabilities;
|
•
|
litigation;
|
•
|
compliance with applicable laws and permits;
|
•
|
material contracts;
|
•
|
labor matters;
|
•
|
benefits matters and ERISA compliance;
|
•
|
real and personal properties;
|
•
|
intellectual property;
|
•
|
environmental matters;
|
•
|
opinion of the Special Committee’s financial advisor;
|
•
|
investment company status;
|
•
|
insurance matters;
|
•
|
related party agreements; and
|
•
|
mortgages.
|
•
|
appear at any meeting of the Taubman shareholders (in person or by proxy), and at every adjournment or postponement thereof, and cause all of the Subject Shares to be counted as present for purposes of calculating a quorum;
|
•
|
vote (or cause to be voted) all the Subject Shares in favor of or, if any action is to be taken by written consent in lieu of a meeting of Taubman’s shareholders, deliver to Taubman a duly executed affirmative written consent in favor of (to the extent applicable), (i) the approval and adoption of the merger agreement and the Transactions and (ii) any other proposal in respect of which the vote or written consent of the Taubman shareholders is requested that could reasonably be expected to facilitate the Transactions; and
|
•
|
vote (or cause to be voted) against, and not provide any written consent for, (i) the adoption or approval of any Acquisition Proposal (as defined in the merger agreement) and (ii) any other proposal in respect of which the vote or written consent or other approval of the Taubman shareholders is requested that could reasonably be expected to impede, materially interfere with, materially delay or prevent the consummation of the Transactions.
|
•
|
in favor of (i) the approval and adoption of the merger agreement and the Transactions and (ii) any other proposal or action in respect of which the vote or written consent of holders of the Taubman OP units is requested that could reasonably be expected to facilitate the consummation of the Transactions; and
|
•
|
against (i) any Acquisition Proposal and (ii) any other proposal or action in respect of which the vote, consent or other approval of the partners of the Taubman operating partnership is requested that could reasonably be expected to impede, materially interfere with, materially delay or prevent the consummation of the Transactions.
|
•
|
(i) directly or indirectly sell, assign, transfer (including by merger or by operation of law), encumber, pledge, grant a participation in, participate in any tender or exchange offer, assign or otherwise dispose of, whether by liquidation, dissolution, dividend, distribution or otherwise any Subject Interests or the beneficial ownership thereof, (ii) deposit any Subject Interests into a voting trust or enter into a voting agreement or arrangement with respect to any Subject Interests or the beneficial ownership thereof or grant or agree to grant any proxy or power of attorney with respect thereto that is inconsistent with the voting agreement or (iii) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect transfer of any Subject Interests or the beneficial ownership thereof; provided that the Taubman family members may transfer Subject Interests to (a) certain affiliates, including other Taubman family members and certain other affiliates provided that such transferee, to the extent not already a party to the voting agreement, agrees in writing to be bound as a party under the voting agreement, or to (b) certain other permitted transferees, including through transfers (1) made in connection with estate planning purposes, (2) to a charitable institution for philanthropic purposes, (3) pursuant to any trust or will of a Taubman family member, or by the laws of intestate succession, (4) pursuant to a qualified domestic relations order or as required by a divorce settlement, or (5) in connection with the payment of the exercise price and/or the satisfaction of any tax withholding obligations arising from the vesting of any restricted shares or other equity awards or the conversion of any convertible securities, provided that in the case of clauses (1) and (2) such transferee, to the extent not already a party to the voting agreement, agrees in writing to be bound as a party under the voting agreement.
|
•
|
the termination of the merger agreement;
|
•
|
the effective time of the REIT Merger; or
|
•
|
the Taubman family representative providing written notice to Simon that it is terminating the voting agreement following (i) a Taubman Board recommendation change, or (ii) any amendment, waiver, modification or other change to any provision of the merger agreement that (a) decreases the amount or changes the form of the Merger Consideration (as defined in the merger agreement) or (b) is otherwise adverse in any material respect to the Taubman family members who are party to the voting agreement or to the Taubman shareholders.
|
•
|
interpret the terms and provisions of the merger agreement, the voting agreement and certain other agreements to be executed by the Taubman family members in connection with the Transactions;
|
•
|
execute and deliver and receive deliveries of such other agreements and all other certificates, statements, notices, approvals, extensions, waivers, undertakings, amendments and other documents required or permitted to be given in connection with the consummation of the Transactions;
|
•
|
terminate the voting agreement on behalf of the Taubman family members in accordance with the terms of the voting agreement;
|
•
|
act as the Taubman family representative for the purposes of the merger agreement;
|
•
|
receive service of process on behalf of the Taubman family members in connection with any claims under the merger agreement, the voting agreement or the other agreements entered into in connection with the Transactions, and agree to, negotiate and enter into settlements and compromises of, and assume the defense of, claims, and comply with orders of courts with respect to such claims;
|
•
|
give and receive notices and communications; and
|
•
|
take all actions necessary or appropriate in his judgment on behalf of the Taubman family members in connection with the merger agreement, the voting agreement and certain other agreements to be entered into in connection with the Transactions.
|
•
|
Up to 20% of the Taubman family’s initial equity in the Joint Venture may be exchanged following the second anniversary of the closing; up to 40% following the third anniversary of the closing; up to 60% following the fourth anniversary of the closing; up to 80% following the fifth anniversary of the closing; and up to 100% following the sixth anniversary of the closing (in each case, inclusive of any prior exchanges).
|
•
|
In addition, between the second and third anniversaries of the closing (i.e., between 24 to 36 months thereafter), the Taubman family members may exchange 100% of their equity in the Joint Venture.
|
Name
|
| |
Age
|
| |
Position With the Company
|
Mayree C. Clark
|
| |
64
|
| |
Director
|
Michael J. Embler
|
| |
57
|
| |
Director
|
Janice L. Fields
|
| |
64
|
| |
Director
|
Michelle J. Goldberg
|
| |
52
|
| |
Director
|
Nancy Killefer
|
| |
67
|
| |
Director
|
Cia Buckley Marakovits
|
| |
55
|
| |
Director
|
Ronald W. Tysoe
|
| |
66
|
| |
Director
|
Myron E. Ullman, III
|
| |
73
|
| |
Director
|
Robert S. Taubman
|
| |
66
|
| |
Chairman of the Taubman Board, President and Chief Executive Officer
|
Simon J. Leopold
|
| |
52
|
| |
Executive Vice President, Chief Financial Officer and Treasurer
|
William S. Taubman
|
| |
61
|
| |
Chief Operating Officer
|
Paul A. Wright
|
| |
49
|
| |
President, Taubman Asia
|
(1)
|
The National Association of Real Estate Investment Trusts defines FFO as net income (calculated in accordance with GAAP), excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.
|
(2)
|
The Company presents adjusted versions of FFO when used by management to evaluate operating performance when certain significant items have impacted results that affect comparability with prior or future periods due to the nature or amounts of these items. The Company believes the disclosure of the adjusted items is similarly useful to investors and others to understand management’s view on comparability of such measures between periods.
|
|
| |
TCO
|
||||||
|
| |
High
|
| |
Low
|
| |
Dividends
Declared |
Fiscal 2018
|
| |
|
| |
|
| |
|
First Quarter
|
| |
$66.61
|
| |
$54.88
|
| |
$0.655
|
Second Quarter
|
| |
61.02
|
| |
50.65
|
| |
0.655
|
Third Quarter
|
| |
65.50
|
| |
57.48
|
| |
0.655
|
Fourth Quarter
|
| |
60.10
|
| |
43.44
|
| |
0.655
|
|
| |
|
| |
|
| |
|
Fiscal 2019
|
| |
|
| |
|
| |
|
First Quarter
|
| |
$54.07
|
| |
$44.28
|
| |
$0.675
|
Second Quarter
|
| |
54.50
|
| |
40.09
|
| |
0.675
|
Third Quarter
|
| |
44.05
|
| |
37.70
|
| |
0.675
|
Fourth Quarter
|
| |
40.85
|
| |
29.52
|
| |
0.675
|
|
| |
|
| |
|
| |
|
Fiscal 2020
|
| |
|
| |
|
| |
|
First Quarter
|
| |
$53.40
|
| |
$26.24
|
| |
$0.675
|
Second Quarter (through April 24, 2020)
|
| |
$47.51
|
| |
$34.51
|
| |
$—
|
Directors, Named Executive Officers and
More Than 5% Shareholders(1) |
| |
Number of
Shares Owned Directly or Indirectly |
| |
Number of Shares
Which Can Be Acquired Within 60 Days of Record Date Held in Deferral Plans(3) |
| |
Number of Shares
Beneficially Owned |
| |
Percent of
Shares |
Robert S. Taubman
|
| |
25,667,759
|
| |
—
|
| |
25,667,759(4)(9)
|
| |
29.3
|
Simon J. Leopold
|
| |
43,919
|
| |
—
|
| |
43,919(5)
|
| |
*
|
William S. Taubman
|
| |
25,297,685
|
| |
—
|
| |
25,297,685(6)(9)
|
| |
28.8
|
Mayree C. Clark
|
| |
9,690
|
| |
—
|
| |
9,690
|
| |
*
|
Michael J. Embler
|
| |
5,000
|
| |
7,036
|
| |
12,036
|
| |
*
|
Janice L. Fields
|
| |
—
|
| |
7,352
|
| |
7,352
|
| |
*
|
Michelle J. Goldberg
|
| |
—
|
| |
5,425
|
| |
5,425
|
| |
*
|
Nancy Killefer
|
| |
1,682
|
| |
4,818
|
| |
6,500
|
| |
*
|
Paul A. Wright
|
| |
14,397
|
| |
—
|
| |
14,397
|
| |
*
|
Cia Buckley Marakovits
|
| |
4,000
|
| |
15,544
|
| |
19,544
|
| |
*
|
Ronald W. Tysoe
|
| |
—
|
| |
29,767
|
| |
29,767
|
| |
*
|
Myron E. Ullman, III
|
| |
15,025
|
| |
20,758
|
| |
35,783
|
| |
*
|
Peter J. Sharp(2)
|
| |
8,744
|
| |
—
|
| |
8,744
|
| |
*
|
The Estate of A. Alfred Taubman
|
| |
22,503,279
|
| |
—
|
| |
22,503,279(7)(9)
|
| |
25.7
|
Gayle Taubman Kalisman
200 E. Long Lake Road, Suite 180 Bloomfield Hills, MI 48304 |
| |
22,976,268
|
| |
—
|
| |
22,976,268(8)(9)
|
| |
26.2
|
Taubman Ventures Group LLC
200 E. Long Lake Road, Suite 180 Bloomfield Hills, MI 48304 |
| |
22,498,279
|
| |
—
|
| |
22,498,279(9)
|
| |
25.7
|
The Vanguard Group, Inc.
100 Vanguard Blvd. Malvern, PA 19355 |
| |
8,843,584
|
| |
—
|
| |
8,843,584(10)
|
| |
10.1
|
BlackRock, Inc.
55 East 52nd Street New York, NY 10055 |
| |
6,889,162
|
| |
—
|
| |
6,889,162(11)
|
| |
7.9
|
Cohen & Steers, Inc.
280 Park Avenue, 10th Floor New York, NY 10017 |
| |
5,718,034
|
| |
—
|
| |
5,718,034(12)
|
| |
6.5
|
FMR LLC
245 Summer Street Boston, MA 02210 |
| |
3,422,496
|
| |
—
|
| |
3,422,496(13)
|
| |
3.9
|
Directors and Executive Officers as a group (12 persons)
|
| |
26,041,872
|
| |
90,700
|
| |
26,132,572(14)
|
| |
29.8
|
*
|
less than 1%
|
(1)
|
We have relied upon information supplied by certain beneficial owners and upon information contained in filings with the SEC. Share figures shown assume that outstanding TRG units are not exchanged for common stock under the Continuing Offer (which TRG units may be exchanged at a ratio of one share of Taubman common stock for every TRG unit) and that outstanding shares of Taubman Series B preferred stock are not converted into Taubman common stock (which is permitted, under specified circumstances, at the ratio of one share
|
(2)
|
Mr. Sharp ceased to be employed with Taubman on October 9, 2019.
|
(3)
|
Under Taubman Centers, Inc. Non-Employee Directors’ Deferred Compensation Plan, the TCO RSUs granted are fully vested at the time of grant but do not have voting rights. The deferral period continues until the earlier of the termination of director service or a change of control.
|
(4)
|
Consists of (A) 38,314 shares of Taubman Series B preferred stock owned by R. Taubman, 1,338,496 shares of Taubman Series B preferred stock owned by R & W-TRG LLC (R&W), a company owned by R. Taubman and his brother, W. Taubman (shared voting and dispositive power), 22,311,442 shares of Taubman Series B preferred stock owned by TVG (shared voting and dispositive power), 5,000 shares of Taubman Series B preferred stock owned by TG Partners (shared voting and dispositive power), and 472,650 shares of Taubman Series B preferred stock owned by TF Associates, LLC (“TFA”) (shared voting and dispositive power) (in aggregate, 92.7% of the Taubman Series B preferred stock) and (B) 267,395 shares of Taubman common stock that R. Taubman owns, 265,246 shares of Taubman common stock that RSTCO, LLC owns, 42,880 shares of Taubman common stock owned by an irrevocable trust for which R. Taubman is the sole trustee for the benefit of R. Taubman and his children, 27,895 shares of Taubman common stock owned in UTMA accounts for the benefit of his children, 711,504 shares of Taubman common stock owned by R&W (shared voting and dispositive power), 186,837 shares of Taubman common stock owned by TVG (shared voting and dispositive power), and 100 shares of Taubman common stock owned by the Revocable Trust (shared voting and dispositive power).
|
(5)
|
Consists of (A) 21,967 shares of Series B preferred stock, and (B) 21,932 shares of Taubman common stock and 20 shares of Taubman common stock on an as-converted basis held through a stock fund of the 401(k) plan, all owned by Simon Leopold.
|
(6)
|
Consists of (A) 25,036 shares of Taubman Series B preferred stock owned by W. Taubman, 1,338,496 shares of Taubman Series B preferred stock owned by R&W (shared voting and dispositive power), 22,311,442 shares of Taubman Series B preferred stock owned by TVG (shared voting and dispositive power), 5,000 shares of Taubman Series B preferred stock owned by TG Partners (shared voting and dispositive power) and 472,650 shares of Taubman Series B preferred stock owned by TFA (shared voting and dispositive power) (in aggregate, 92.6% of the Taubman Series B preferred stock), and (B) 43,032 shares of Taubman common stock that W. Taubman owns, 203,588 shares of Taubman common stock that WSTCO, LLC owns, 711,504 shares of Taubman common stock owned by R&W (shared voting and dispositive power), 186,837 shares of Taubman common stock owned by TVG (shared voting and dispositive power), and 100 shares of Taubman common stock owned by the Revocable Trust (shared voting and dispositive power).
|
(7)
|
Consists of (A) 22,311,442 shares of Taubman Series B preferred stock owned by TVG (shared voting and dispositive power) and 5,000 shares of Taubman Series B preferred stock owned by TG Partners (in aggregate, 85.6% of the Taubman Series B preferred stock), and (B) 186,837 shares of Taubman common stock owned by TVG (shared voting and dispositive power). The Estate of A. Alfred Taubman disclaims beneficial ownership in the Taubman voting stock owned by TVG and TG Partners beyond its pecuniary interest in those entities.
|
(8)
|
Consists of (A) 239 shares of Taubman Series B preferred stock owned by G. Taubman Kalisman, 22,311,442 shares of Taubman Series B preferred stock owned by TVG (shared voting and dispositive power), 5,000 shares of Taubman Series B preferred stock owned by TG Partners (shared voting and dispositive power) and 472,650 shares of Taubman Series B preferred stock owned by TFA (shared voting and dispositive power) (in aggregate, 87.4% of the Taubman Series B preferred stock), and (B) 186,837 shares of Taubman common stock owned by TVG (shared voting and dispositive power) and 100 shares of Taubman common stock owned by the Revocable Trust (shared voting and dispositive power).
|
(9)
|
R. Taubman, W. Taubman and G. Taubman Kalisman are co-trustees of the Revocable Trust, and share voting and dispositive power over 100 shares of Taubman common stock owned by such estate. The Estate of A. Alfred Taubman, R. Taubman, W. Taubman and G. Taubman Kalisman may be deemed to beneficially own 186,837 shares of Taubman common stock owned by TVG, 5,000 shares of Taubman Series B preferred stock owned by TG Partners and 22,311,442 shares of Taubman Series B preferred stock owned by TVG. R. Taubman, W. Taubman and G. Taubman Kalisman may be deemed to beneficially own 472,650 shares of Taubman Series B preferred stock owned by TFA. Such amounts are disclosed in notes 4, 6, 7 and 8. Each person disclaims beneficial ownership in the Taubman voting stock owned by TVG, TFA, TG Partners and the Revocable Trust beyond such person’s pecuniary interest in such entities.
|
(10)
|
Pursuant to Schedule 13G/A filed with the SEC on February 11, 2020. Represents 14.4% of the Taubman common stock. The Vanguard Group, Inc. has sole power to vote 90,170 shares, shared power to vote 73,527 shares, sole power to dispose 8,747,324 shares, and shared power to dispose 96,260 shares.
|
(11)
|
Pursuant to Schedule 13G/A filed with the SEC on February 4, 2020. Represents 11.2% of the Taubman common stock. This report includes holdings of various subsidiaries of the holding company. BlackRock, Inc. has sole power to vote 6,628,526 shares and sole power to dispose 6,889,162 shares.
|
(12)
|
Pursuant to a Schedule 13G/A filed with the SEC on February 14, 2020. Represents 9.3% of the Taubman common stock. This report includes holdings of various subsidiaries of the holding company. Cohen & Steers, Inc. has sole power to vote 5,188,824 shares and sole power to dispose 5,718,034 shares.
|
(13)
|
Pursuant to a Schedule 13G filed with the SEC on February 7, 2020. Represents 5.6% of the Taubman common stock. This report includes holdings of various subsidiaries of the holding company. FMR LLC has sole power to vote 302,133 shares and sole power to dispose 3,422,496 shares.
|
(14)
|
Consists of an aggregate of (A) 24,212,905 shares of Taubman Series B preferred stock beneficially owned (in aggregate, 92.8% of the Taubman Series B preferred stock), and (B) 1,828,967 shares of Taubman common stock beneficially owned and 90,700 shares of Taubman common stock subject to issuance under the Non-Employee Directors’ Deferred Compensation Plan (in aggregate, 3.1% of the Taubman common stock). See notes 4 and 6 for shares and units pledged as collateral.
|
Name
|
| |
Age
|
| |
Position With the Company
|
Glyn F. Aeppel
|
| |
61
|
| |
Director
|
Larry C. Glasscock
|
| |
71
|
| |
Director
|
Karen N. Horn, Ph.D.
|
| |
76
|
| |
Director
|
Allan Hubbard
|
| |
72
|
| |
Director
|
Reuben S. Leibowitz
|
| |
72
|
| |
Director
|
Gary M. Rodkin
|
| |
67
|
| |
Director
|
Stefan M. Selig
|
| |
57
|
| |
Director
|
Daniel C. Smith, Ph.D.
|
| |
62
|
| |
Director
|
J. Albert Smith, Jr.
|
| |
79
|
| |
Director
|
Marta R. Stewart
|
| |
62
|
| |
Director
|
David Simon
|
| |
58
|
| |
Chairman of the Board, Chief Executive Officer and President
|
Richard S. Sokolov
|
| |
70
|
| |
Director, Vice Chairman
|
Herbert Simon
|
| |
85
|
| |
Director, Chairman Emeritus of the Board
|
Steven E. Fivel
|
| |
59
|
| |
General Counsel and Secretary
|
Brian J. McDade
|
| |
40
|
| |
Executive Vice President, Chief Financial Officer and Treasurer
|
John Rulli
|
| |
63
|
| |
President of Malls and Chief Administrative Officer
|
Alexander L.W. Snyder
|
| |
50
|
| |
Assistant General Counsel and Assistant Secretary
|
•
|
Taubman’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on February 27, 2020;
|
•
|
The portions of our Definitive Proxy Statement under Regulation 14A in connection with Taubman’s 2019 Annual Meeting of Shareholders, filed with the SEC on April 30, 2019, that are incorporated by reference in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018; and
|
•
|
Taubman’s Current Reports on Form 8-K, filed on February 10, 2020, February 10, 2020, February 11, 2020 and March 20, 2020.
|
|
| |
Page
|
|||
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
| |
|
| | |||||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
| |
|
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | |
|
| |
Page
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
|||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
|||
| | |||||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
Taubman Centers, Inc.
|
| |
|
|||
200 East Long Lake Road, Suite 300
|
| |
|
|||
Bloomfield Hills, Michigan 48304
|
| |
|
|||
Phone: 248-258-6800
|
| |
|
|||
Attention:
|
| |
Chris B. Heaphy
|
| |
|
E-mail:
|
| |
cheaphy@taubman.com
|
| |
|
|
| |
|
| |
|
|
| |
SIMON PROPERTY GROUP, INC.,
a Delaware corporation |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ David Simon
|
|
| |
Name:
|
| |
David Simon
|
|
| |
Title:
|
| |
Chairman of the Board, Chief Executive Officer and President
|
|
| |
|
| |
|
|
| |
SIMON PROPERTY GROUP, L.P.,
a Delaware limited partnership |
|||
|
| |
|
|||
|
| |
By:
|
| |
SIMON PROPERTY GROUP, INC.,
a Delaware corporation, its General Partner |
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ David Simon
|
|
| |
Name:
|
| |
David Simon
|
|
| |
Title:
|
| |
Chairman of the Board, Chief Executive Officer and President
|
|
| |
|
|||
|
| |
SILVER MERGER SUB 1, LLC,
a Delaware limited liability company |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ David Simon
|
|
| |
Name:
|
| |
David Simon
|
|
| |
Title:
|
| |
Chief Executive Officer and President
|
|
| |
|
| |
|
|
| |
SILVER MERGER SUB 2, LLC,
a Delaware limited liability company |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ David Simon
|
|
| |
Name:
|
| |
David Simon
|
|
| |
Title:
|
| |
Chief Executive Officer and President
|
|
| |
TAUBMAN CENTERS, INC.,
a Michigan corporation |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
Name:
|
| |
Robert S. Taubman
|
|
| |
Title:
|
| |
Chairman of the Board, Chief Executive Officer and President
|
|
| |
|
| |
|
|
| |
THE TAUBMAN REALTY GROUP LIMITED PARTNERSHIP,
a Delaware limited partnership |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
TAUBMAN CENTERS, INC.,
a Michigan corporation, its Managing General Partner |
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
Name:
|
| |
Robert S. Taubman
|
|
| |
Title:
|
| |
Chairman of the Board, Chief Executive Officer and President
|
|
| |
|
| |
Page
|
|
| |
|
| |
|
VI. MANAGEMENT.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
| |
|
VII. COMPANY BUSINESS AND STRATEGY; BUSINESS OPPORTUNITIES; COMPANY POLICIES.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
|
| |
|
| |
|
VIII. TRANSFERS OF MEMBERSHIP INTERESTS; EXCHANGE RIGHTS; REGISTRATION RIGHTS.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | |
|
| |
|
| |
Page
|
|
| |
|
| |
|
IX. WITHHOLDING AND DOCUMENTATION.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
|
| |
|
| |
|
X. DISSOLUTION OF THE COMPANY, WINDING UP, AND LIQUIDATION.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
|
| |
|
| |
|
XI. MISCELLANEOUS.
|
| |
|
|||
|
| |
|
| |
|
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | | |||
| | | |
Schedule I
|
| |
Members and Preferred Holders
|
Schedule II
|
| |
Designated Properties
|
Schedule III
|
| |
Permitted Competing Activities
|
Schedule IV
|
| |
Capital Accounts
|
Schedule V
|
| |
Certain Agreements
|
Schedule VI
|
| |
Section 6.28 Properties
|
Schedule VII
|
| |
Initial Mandatory Minimum
|
Schedule VIII
|
| |
TTC Restructuring
|
|
| |
|
Exhibit A
|
| |
Form of Membership Interest Certificate
|
Exhibit B
|
| |
Adoption Agreement
|
Exhibit C
|
| |
Illustrative FFO Calculations
|
Exhibit D
|
| |
Total Rewards Policy
|
Exhibit E
|
| |
Initial Annual Operating Budget
|
Exhibit F
|
| |
Initial Annual Capital Expenditure Budget
|
Exhibit G
|
| |
Permitted Affiliate Transactions
|
Exhibit H
|
| |
Series A Preferred Unit Designation
|
Exhibit I
|
| |
REIT Requirements
|
Exhibit J
|
| |
Initial Directors
|
Exhibit K
|
| |
Treatment of Certain Equity Interests
|
Exhibit L
|
| |
Total Equity Value
|
Exhibit M
|
| |
Form of Voting Agreement
|
Exhibit N
|
| |
OpComm Waiver
|
Period
|
| |
Amount
|
At any time following the two (2)-year anniversary of the Effective Date
|
| |
Up to 20%
|
At any time following the three (3)-year anniversary of the Effective Date
|
| |
Up to 40% (inclusive of any prior Exchanges)
|
At any time following the four (4)-year anniversary of the Effective Date
|
| |
Up to 60% (inclusive of any prior Exchanges)
|
At any time following the five (5)-year anniversary of the Effective Date
|
| |
Up to 80% (inclusive of any prior Exchanges)
|
At any time following the six (6)-year anniversary of the Effective Date
|
| |
Up to 100% (inclusive of any prior Exchanges)
|
If to the Company:
|
| |
[COMPANY ADDRESS]
|
|
Email: [EMAIL ADDRESS]
|
||
|
Attention: [TITLE OF OFFICER TO RECEIVE NOTICES]
|
||
|
| |
|
with a copy to:
|
| |
[COMPANY LAW FIRM AND ADDRESS]
|
|
Email: [EMAIL ADDRESS]
|
||
|
Attention: [ATTORNEY NAME]
|
||
|
|
||
|
and
|
||
|
|
||
|
each of the Silver Member and the Titanium Family Designee, at its respective mailing address or email address, as set forth on Schedule I.
|
||
|
| |
|
If to a Member:
|
| |
To such Member's respective mailing address or email address, as set forth on Schedule I.
|
|
| |
MEMBERS:
|
|||
|
| |
|
| |
|
|
| |
SILVER MERGER SUB 1, LLC,
a Delaware limited liability company |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
|
|
| |
|
| |
Name:
|
|
| |
|
| |
Title:
|
|
| |
|
| |
|
|
| |
[TITANIUM FAMILY GROUP MEMBERS],
a [[•]] |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
|
|
| |
|
| |
Name:
|
|
| |
|
| |
Title:
|
|
| |
|
| |
|
|
| |
OTHER PARTIES:
|
|||
|
| |
|
| |
|
|
| |
SIMON PROPERTY GROUP, INC.,
a Delaware corporation |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
|
|
| |
|
| |
Name:
|
|
| |
|
| |
Title:
|
|
| |
|
| |
|
|
| |
SIMON PROPERTY GROUP, L.P.,
a Delaware limited partnership |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
|
|
| |
|
| |
Name:
|
|
| |
|
| |
Title:
|
|
| |
|
| |
|
|
| |
TAUBMAN VENTURES GROUP, LLC, SOLELY IN
|
|||
|
| |
ITS CAPACITY AS PARTNERSHIP
|
|||
|
| |
REPRESENTATIVE
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
|
|
| |
|
| |
Name:
|
|
| |
|
| |
Title:
|
|
| |
SOLELY WITH RESPECT TO HIS OBLIGATIONS UNDER SECTION 7.3 AND, TO THE EXTENT HE IS SERVING AS CHIEF EXECUTIVE OFFICER, HIS CEO OBLIGATIONS:
|
|
| |
|
|
| |
ROBERT S. TAUBMAN
|
|
| |
|
|
| |
SOLELY WITH RESPECT TO HIS OBLIGATIONS UNDER SECTION 7.3 AND, TO THE EXTENT HE IS SERVING AS CHIEF EXECUTIVE OFFICER, HIS CEO OBLIGATIONS:
|
|
| |
|
|
| |
WILLIAM S. TAUBMAN
|
|
| |
Lazard Frères & Co. LLC
30 Rockefeller Plaza New York, NY 10112 |
(i)
|
Reviewed the financial terms and conditions of the Agreement;
|
(ii)
|
Reviewed certain publicly available historical business and financial information relating to Company;
|
(iii)
|
Reviewed various financial forecasts and other data provided to us by Company relating to the business of Company;
|
(iv)
|
Held discussions with members of the senior management of Company with respect to the business and prospects of Company;
|
(v)
|
Reviewed public information with respect to certain other companies in lines of business we believe to be generally relevant in evaluating the business of Company;
|
(vi)
|
Reviewed the financial terms of certain business combinations involving companies in lines of business we believe to be generally relevant in evaluating the business of Company;
|
(vii)
|
Reviewed historical stock prices and trading volumes of Common Stock; and
|
(viii)
|
Conducted such other financial studies, analyses and investigations as we deemed appropriate.
|
|
| |
Very truly yours,
|
|||
|
| |
LAZARD FRERES & CO. LLC
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Matthew J. Lustig
|
|
| |
|
| |
Matthew J. Lustig
Managing Director |
|
| |
if to Parent:
|
||||||
|
| |
|
| |
|
| |
|
|
| |
|
| |
Simon Property Group, Inc.
|
|||
|
| |
|
| |
225 West Washington Street
|
|||
|
| |
|
| |
Indianapolis, Indiana 46204
|
|||
|
| |
|
| |
Phone:
|
| |
317-636-1600
|
|
| |
|
| |
Attn:
|
| |
Steven E. Fivel
|
|
| |
|
| |
E-mail:
|
| |
sfivel@simon.com
|
|
| |
if to any of the Holders:
|
||||||
|
| |
|
| |
|
| |
|
|
| |
|
| |
c/o Titanium Family Representative
|
|||
|
| |
|
| |
Taubman Ventures Management
|
|||
|
| |
|
| |
200 East Long Lake Road, Suite 180
|
|||
|
| |
|
| |
Bloomfield Hills, MI 48304
|
|||
|
| |
|
| |
Phone:
|
| |
248-258-7303
|
|
| |
|
| |
Attn:
|
| |
Robert S. Taubman
|
|
| |
|
| |
E-mail:
|
| |
rtaubman@taubmgmt.com
|
|
| |
SIMON PROPERTY GROUP, INC.,
a Delaware corporation |
||||||
|
| |
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ David Simon
|
|||
|
| |
|
| |
Name:
|
| |
David Simon
|
|
| |
|
| |
Title:
|
| |
Chairman of the Board, Chief Executive Officer and President
|
|
| |
R & W-TRG LLC, a Michigan
limited liability company |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
Robert S. Taubman, Manager
|
|
| |
|
| |
|
|
| |
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
William S. Taubman, Manager
|
|
| |
/s/ Robert S. Taubman
|
|
| |
Robert S. Taubman, as Trustee of the Robert S. Taubman Revocable Trust under Agreement dated August 9, 1982, as amended
|
|
| |
/s/ William S. Taubman
|
|
| |
William S. Taubman, as Trustee of the William S. Taubman Revocable Trust under Agreement dated June 10, 1993, as amended
|
|
| |
/s/ Robert S. Taubman
|
|
| |
Robert S. Taubman, as Trustee of the Family Trust created under the Julia Reyes Taubman Trust Agreement dated 10/7/2015
|
|
| |
TAUBMAN VENTURES GROUP LLC,
a Michigan limited liability company |
|||||||||
|
| |
|
| |
|
| |
|
| |
|
|
| |
By:
|
| |
All of the Voting Common Members:
|
||||||
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
ESTATE OF A. ALFRED TAUBMAN
|
|||
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
By:
|
| |
/s/ Gayle Taubman Kalisman
|
|
| |
|
| |
|
| |
|
| |
Gayle Taubman Kalisman, Personal Representative
|
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
|
| |
|
| |
Robert S. Taubman, Personal Representative
|
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
|
| |
|
| |
William S. Taubman, Personal Representative
|
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
RST SUB-TRAP, LLC, a Delaware limited liability company
|
|||
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
|
| |
|
| |
Robert S. Taubman, Managing Member
|
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
WST SUB-TRAP, LLC, a Delaware limited liability company
|
|||
|
| |
|
| |
|
| |||||
|
| |
|
| |
|
| |
By:
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
|
| |
|
| |
William S. Taubman, Managing Member
|
|
| |
|
| |
|
| |||||
|
| |
|
| |
|
| |
GTK SUB-TRAP, LLC, a Delaware limited liability company
|
|||
|
| |
|
| |
|
| |||||
|
| |
|
| |
|
| |
By:
|
| |
/s/ Gayle Taubman Kalisman
|
|
| |
|
| |
|
| |
|
| |
Gayle Taubman Kalisman, Managing Member
|
|
| |
A. ALFRED TAUBMAN RESTATED REVOCABLE TRUST, AS AMENDED AND RESTATED IN ITS ENTIRETY BY INSTRUMENT DATED DECEMBER 2, 2014
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Gayle Taubman Kalisman
|
|
| |
|
| |
Gayle Taubman Kalisman, Trustee
|
|
| |
|
| |
|
|
| |
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
Robert S. Taubman, Trustee
|
|
| |
|
| |
|
|
| |
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
William S. Taubman, Trustee
|
|
| |
RSTCO, LLC, a Delaware
limited liability company |
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
Robert S. Taubman, Manager
|
|
| |
WSTCO, LLC, a Delaware limited liability company
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
William S. Taubman, Manager
|
|
| |
/s/ Gayle Taubman Kalisman
|
|
| |
Gayle Taubman Kalisman, as Trustee of the Gayle Taubman Kalisman Revocable Trust under Agreement dated March 22, 1981, as amended
|
|
| |
TG PARTNERS, LLC, a Delaware
limited liability company |
||||||
|
| |
|
| |
|
| |
|
|
| |
By:
|
| |
TG Michigan, Inc., a Michigan corporation
|
|||
|
| |
|
| |
|
| |
|
|
| |
Its:
|
| |
Manager Member
|
|||
|
| |
|
| |
|
| |
|
|
| |
|
| |
By:
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
|
| |
Robert S. Taubman, President
|
|
| |
TF ASSOCIATES, LLC, a Michigan
limited liability company |
|||
|
| |
|
| |
|
|
| |
By Its Members:
|
|||
|
| |
|
| |
|
|
| |
|
| |
/s/ Gayle Taubman Kalisman
|
|
| |
|
| |
Gayle Taubman Kalisman, as Trustee of the GTK 2017 Philip Taubman Kalisman Grantor Retained Annuity Trust under Agreement dated November 6, 2017 and the GTK 2017 Jason Taubman Kalisman Grantor Retained Annuity Trust under Agreement dated November 6, 2017
|
|
| |
|
| |
|
|
| |
|
| |
/s/ Robert S. Taubman
|
|
| |
|
| |
Robert S. Taubman, as Trustee of the RST 2017 Alexander Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017, the RST 2017 Ghislaine Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017, the RST 2017 Sebastian Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017, and the RST 2017 Theodore Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017
|
|
| |
|
| |
|
|
| |
|
| |
/s/ William S. Taubman
|
|
| |
|
| |
William S. Taubman, as Trustee of the WST 2017 Oliver Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017, and the WST 2017 Abigail Taubman Grantor Retained Annuity Trust under Agreement dated November 6, 2017
|
|
Holder
|
| |
Number of Subject
Shares of Titanium Common Stock Owned (Record or Beneficial) |
| |
Number of Subject
Shares of Titanium Series B Preferred Stock Owned (Record or Beneficial) |
| |
Number of Subject
Units of Titanium OP Units Owned (Record or Beneficial) |
|
|
R & W-TRG LLC
|
| |
711,504
|
| |
1,338,496
|
| |
1,338,496
|
|
|
Robert S. Taubman Revocable Trust under Agreement dated August 9, 1982, as amended
|
| |
267,395
|
| |
38,314
|
| |
38,314
|
|
|
William S. Taubman Revocable Trust under Agreement dated June 10, 1993, as amended
|
| |
43,032
|
| |
25,036
|
| |
25,036
|
|
|
Family Trust created under the Julia Reyes Taubman Trust Agreement dated October 7, 2015
|
| |
42,880
|
| |
0
|
| |
0
|
|
|
Taubman Ventures Group LLC
|
| |
186,837
|
| |
22,311,442
|
| |
22,311,442
|
|
|
A. Alfred Taubman Restated Revocable Trust, as amended and restated in its entirety by Instrument dated December 2, 2014
|
| |
100
|
| |
0
|
| |
0
|
|
|
RSTCO, LLC
|
| |
265,246
|
| |
0
|
| |
0
|
|
|
WSTCO, LLC
|
| |
203,588
|
| |
0
|
| |
0
|
|
|
Gayle Taubman Kalisman Revocable Trust under Agreement dated March 22, 1981, as amended
|
| |
0
|
| |
239
|
| |
239
|
|
|
TG Partners, LLC
|
| |
0
|
| |
5,000
|
| |
5,000
|
|
|
TF ASSOCIATES, LLC
|
| |
0
|
| |
472,650
|
| |
472,650
|
|